(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of CTNNB1 protein CTD PMID:12387456 (-)-demecolcine increases expression ISO RGD:733705 6480464 Demecolcine results in increased expression of CTNNB1 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:733705 6480464 epigallocatechin gallate results in decreased expression of CTNNB1 mRNA, epigallocatechin gallate results in decreased expression of CTNNB1 protein CTD PMID:16968065 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate promotes the reaction [Sulindac inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of CTNNB1 protein]] CTD PMID:29999212 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1550466 6480464 epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 mRNA], epigallocatechin gallate inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 protein] CTD PMID:27058323 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:1550466 6480464 epigallocatechin gallate results in decreased expression of CTNNB1 protein CTD PMID:12351151 (-)-epigallocatechin 3-gallate decreases localization ISO RGD:733705 6480464 epigallocatechin gallate results in decreased localization of CTNNB1 protein CTD PMID:16968065 (-)-epigallocatechin 3-gallate decreases phosphorylation ISO RGD:733705 6480464 epigallocatechin gallate results in decreased phosphorylation of CTNNB1 protein CTD PMID:16968065 (R)-adrenaline multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Epinephrine results in increased phosphorylation of CTNNB1 protein], Niclosamide inhibits the reaction [Epinephrine results in increased phosphorylation of CTNNB1 protein] CTD PMID:26964897 (R)-adrenaline increases phosphorylation EXP 6480464 Epinephrine results in increased phosphorylation of CTNNB1 protein CTD PMID:26964897 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane increases expression ISO RGD:733705 6480464 2, 2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CTNNB1 mRNA CTD PMID:16580782 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane increases activity ISO RGD:733705 6480464 2, 2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased activity of CTNNB1 protein CTD PMID:19238344 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane multiple interactions ISO RGD:733705 6480464 CDH2 protein affects the reaction [2 more ... CTD PMID:16580782 , PMID:19238344 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of CTNNB1 protein CTD PMID:29031619 , PMID:29999212 1,2-dimethylhydrazine multiple interactions ISO RGD:1550466 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CTNNB1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1550466 6480464 1, 2-Dimethylhydrazine results in decreased expression of CTNNB1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [chlorophyllin affects the reaction [1 more ... CTD PMID:12628520 more ... 1,2-dimethylhydrazine increases mutagenesis EXP 6480464 1, 2-Dimethylhydrazine results in increased mutagenesis of CTNNB1 gene CTD PMID:12628520 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of CTNNB1 mRNA CTD PMID:24140754 1-(4-methoxybenzyl)-3-(5-nitro-1,3-thiazol-2-yl)urea multiple interactions ISO RGD:733705 6480464 N-(4-methoxybenzyl)-N'-(5-nitro-1, 3-thiazol-2-yl)urea inhibits the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein] CTD PMID:32305283 17alpha-ethynylestradiol multiple interactions ISO RGD:1550466 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNB1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:733705 6480464 Estradiol inhibits the reaction [ESR1 protein promotes the reaction [BTRC protein binds to CTNNB1 protein]] more ... CTD PMID:16053526 more ... 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with bisphenol A] results in decreased expression of CTNNB1 mRNA more ... CTD PMID:17170212 more ... 17beta-estradiol affects localization EXP 6480464 Estradiol affects the localization of CTNNB1 protein CTD PMID:17170212 17beta-estradiol increases expression ISO RGD:1550466 6480464 Estradiol results in increased expression of CTNNB1 mRNA CTD PMID:14648872 17beta-estradiol multiple interactions ISO RGD:1550466 6480464 [Bromocriptine co-treated with Estradiol] results in decreased expression of CTNNB1 protein, Estradiol results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:11786374 , PMID:23684557 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:733705 6480464 Metribolone promotes the reaction [NDRG1 protein binds to CTNNB1 protein] CTD PMID:17220478 2,2',4,4',5,5'-hexachlorobiphenyl increases degradation EXP 6480464 2 more ... CTD PMID:19464575 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 2 more ... CTD PMID:19464575 2,3,4,7,8-Pentachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550466 6480464 Tetrachlorodibenzodioxin affects the expression of CTNNB1 mRNA CTD PMID:21570461 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CTNNB1 protein CTD PMID:24231000 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733705 6480464 Tetrachlorodibenzodioxin results in increased expression of CTNNB1 mRNA, Tetrachlorodibenzodioxin results in increased expression of CTNNB1 protein CTD PMID:22902829 , PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733705 6480464 Tetrachlorodibenzodioxin results in decreased expression of CTNNB1 protein CTD PMID:22134133 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733705 6480464 Lithium Chloride inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CTNNB1 protein] CTD PMID:22134133 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in decreased expression of CTNNB1 protein more ... CTD PMID:21602191 , PMID:24231000 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1550466 6480464 Tetrachlorodibenzodioxin results in increased expression of CTNNB1 mRNA CTD PMID:17586704 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550466 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNB1 mRNA more ... CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases activity ISO RGD:1550466 6480464 Tetrachlorodibenzodioxin results in decreased activity of CTNNB1 protein CTD PMID:24928892 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 geraniol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 mRNA] more ... CTD PMID:26165751 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 mRNA, Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 protein CTD PMID:26165751 2,6-di-tert-butyl-4-methylphenol multiple interactions ISO RGD:1550466 6480464 [Butylated Hydroxytoluene co-treated with Oxygen] affects the localization of CTNNB1 protein, [Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of CTNNB1 protein CTD PMID:16272459 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CTNNB1 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:733705 6480464 Lactic Acid results in increased expression of CTNNB1 mRNA CTD PMID:30851411 2-methoxy-17beta-estradiol multiple interactions ISO RGD:733705 6480464 2-Methoxyestradiol inhibits the reaction [CTNNB1 protein results in decreased susceptibility to Bortezomib] CTD PMID:18485479 2-methoxy-17beta-estradiol decreases expression ISO RGD:733705 6480464 2-Methoxyestradiol results in decreased expression of CTNNB1 mRNA, 2-Methoxyestradiol results in decreased expression of CTNNB1 protein CTD PMID:18485479 2-nitrotoluene increases mutagenesis ISO RGD:1550466 6480464 2-nitrotoluene results in increased mutagenesis of CTNNB1 gene CTD PMID:13678655 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression EXP 6480464 Puromycin Aminonucleoside results in decreased expression of CTNNB1 protein CTD PMID:12065681 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1550466 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CTNNB1 mRNA CTD PMID:20188158 3,5-dichloro-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxybenzamide multiple interactions EXP 6480464 DRD2 protein affects the reaction [Raclopride results in increased expression of CTNNB1 protein] CTD PMID:16144542 3,5-dichloro-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxybenzamide increases expression EXP 6480464 Raclopride results in increased expression of CTNNB1 protein CTD PMID:16144542 3,5-diethoxycarbonyl-1,4-dihydrocollidine decreases expression ISO RGD:1550466 6480464 3 more ... CTD PMID:23620592 3,5-diethoxycarbonyl-1,4-dihydrocollidine multiple interactions ISO RGD:1550466 6480464 CTNNB1 mutant form inhibits the reaction [3 more ... CTD PMID:23620592 3,5-diethoxycarbonyl-1,4-dihydrocollidine decreases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased susceptibility to 3 more ... CTD PMID:23620592 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO RGD:733705 6480464 [MK-886 binds to and results in decreased activity of PPARA protein] inhibits the reaction [perfluorooctanoic acid results in decreased expression of CTNNB1 protein] CTD PMID:23978332 3-aminobenzamide decreases expression ISO RGD:733705 6480464 3-aminobenzamide results in decreased expression of CTNNB1 mRNA CTD PMID:15670817 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CTNNB1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CTNNB1 mRNA CTD PMID:28628672 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of CTNNB1 protein] CTD PMID:29535048 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1550466 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein more ... CTD PMID:28285642 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases mutagenesis EXP 6480464 2-amino-3-methylimidazo(4, 5-f)quinoline results in increased mutagenesis of CTNNB1 gene CTD PMID:12628520 , PMID:9515794 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine multiple interactions EXP 6480464 [chlorophyllin affects the reaction [2-amino-3-methylimidazo(4 more ... CTD PMID:12628520 3-methylcholanthrene multiple interactions ISO RGD:1550466 6480464 CTNNB1 gene mutant form affects the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA] more ... CTD PMID:21498875 , PMID:25174530 3-methylcholanthrene affects response to substance ISO RGD:1550466 6480464 CTNNB1 protein affects the susceptibility to Methylcholanthrene CTD PMID:21498875 3-methylcholanthrene increases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in increased susceptibility to Methylcholanthrene CTD PMID:25174530 4,4'-diaminodiphenylmethane increases expression ISO RGD:1550466 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CTNNB1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CTNNB1 mRNA CTD PMID:28628672 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:733705 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CTNNB1 protein more ... CTD PMID:28321046 4-hydroxynon-2-enal decreases expression ISO RGD:733705 6480464 4-hydroxy-2-nonenal results in decreased expression of CTNNB1 mRNA, 4-hydroxy-2-nonenal results in decreased expression of CTNNB1 protein CTD PMID:12419474 , PMID:24825450 4-methylthio-2-oxobutanoic acid decreases expression ISO RGD:733705 6480464 2-keto-4-methylthiobutyric acid results in decreased expression of CTNNB1 protein CTD PMID:28414304 4-methylthio-2-oxobutanoic acid decreases expression ISO RGD:1550466 6480464 2-keto-4-methylthiobutyric acid results in decreased expression of CTNNB1 protein CTD PMID:28414304 5-aza-2'-deoxycytidine multiple interactions ISO RGD:733705 6480464 5-furan-2yl-isoxazole-3-carboxylic acid (3-imidazol-1yl-propyl)-amide inhibits the reaction [Decitabine affects the localization of CTNNB1 protein], Decitabine inhibits the reaction [bisphenol A results in decreased expression of CTNNB1 protein] CTD PMID:30125549 , PMID:30303745 5-aza-2'-deoxycytidine increases expression ISO RGD:733705 6480464 Decitabine results in increased expression of CTNNB1 protein CTD PMID:19234609 5-aza-2'-deoxycytidine decreases response to substance ISO RGD:733705 6480464 CTNNB1 protein results in decreased susceptibility to Decitabine CTD PMID:19234609 5-aza-2'-deoxycytidine decreases expression ISO RGD:1550466 6480464 Decitabine results in decreased expression of CTNNB1 mRNA CTD PMID:19222872 5-aza-2'-deoxycytidine affects localization ISO RGD:733705 6480464 Decitabine affects the localization of CTNNB1 protein CTD PMID:19387464 , PMID:30125549 5-aza-2'-deoxycytidine decreases localization ISO RGD:733705 6480464 Decitabine results in decreased localization of CTNNB1 protein CTD PMID:21515334 5-formyltetrahydrofolic acid multiple interactions EXP 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of CTNNB1 protein CTD PMID:25187349 6-bromoindirubin-3'-oxime multiple interactions ISO RGD:733705 6480464 [6-bromoindirubin-3'-oxime co-treated with DHFR mRNA] affects the expression of CTNNB1 protein more ... CTD PMID:19727391 , PMID:31163223 6-bromoindirubin-3'-oxime increases expression ISO RGD:733705 6480464 6-bromoindirubin-3'-oxime results in increased expression of CTNNB1 protein CTD PMID:18624906 , PMID:26259606 6-bromoindirubin-3'-oxime decreases phosphorylation ISO RGD:733705 6480464 6-bromoindirubin-3'-oxime results in decreased phosphorylation of CTNNB1 protein CTD PMID:19727391 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CTNNB1 mRNA CTD PMID:24780913 7,12-dimethyltetraphene increases expression ISO RGD:733705 6480464 9 more ... CTD PMID:29663660 7,12-dimethyltetraphene multiple interactions ISO RGD:733705 6480464 9 more ... CTD PMID:29663660 [6]-Shogaol decreases expression ISO RGD:733705 6480464 shogaol results in decreased expression of CTNNB1 mRNA, shogaol results in decreased expression of CTNNB1 protein CTD PMID:27645308 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CTNNB1 mRNA CTD PMID:31881176 acetylleucyl-leucyl-norleucinal multiple interactions ISO RGD:733705 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [Immunologic Factors results in decreased expression of CTNNB1 protein] CTD PMID:29974605 acetylsalicylic acid decreases localization ISO RGD:733705 6480464 Aspirin results in decreased localization of CTNNB1 protein CTD PMID:16878161 , PMID:17357503 acetylsalicylic acid multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Aspirin results in increased ubiquitination of CTNNB1 protein] more ... CTD PMID:12813129 , PMID:16878161 acetylsalicylic acid increases ubiquitination ISO RGD:733705 6480464 Aspirin results in increased ubiquitination of CTNNB1 protein CTD PMID:16878161 acetylsalicylic acid increases phosphorylation ISO RGD:733705 6480464 Aspirin results in increased phosphorylation of CTNNB1 protein CTD PMID:12813129 , PMID:16878161 acrolein increases expression ISO RGD:733705 6480464 Acrolein results in increased expression of CTNNB1 protein CTD PMID:20525806 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of CTNNB1 mRNA CTD PMID:28959563 Aeroplysinin 1 decreases expression ISO RGD:733705 6480464 aeroplysinin I results in decreased expression of CTNNB1 protein CTD PMID:27120392 AH23848 multiple interactions ISO RGD:733705 6480464 [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] promotes the reaction [AXIN1 protein binds to CTNNB1 protein] more ... CTD PMID:19407222 AICA ribonucleotide increases expression ISO RGD:1550466 6480464 AICA ribonucleotide results in increased expression of CTNNB1 mRNA, AICA ribonucleotide results in increased expression of CTNNB1 protein CTD PMID:21454484 AICA ribonucleotide multiple interactions ISO RGD:1550466 6480464 [AICA ribonucleotide results in increased phosphorylation of HDAC5 protein] which results in increased expression of CTNNB1 mRNA more ... CTD PMID:21454484 aldehydo-D-glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] CTD PMID:18004065 aldehydo-D-glucose multiple interactions ISO RGD:733705 6480464 DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA], DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein] CTD PMID:29163160 aldehydo-D-glucose increases expression ISO RGD:733705 6480464 Glucose results in increased expression of CTNNB1 mRNA, Glucose results in increased expression of CTNNB1 protein CTD PMID:29163160 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of CTNNB1 mRNA, Glucose results in decreased expression of CTNNB1 protein CTD PMID:18004065 , PMID:21818840 all-trans-retinoic acid multiple interactions ISO RGD:1550466 6480464 [Cholecalciferol co-treated with Tretinoin] affects the localization of CTNNB1 protein, Tretinoin inhibits the reaction [Cholecalciferol results in increased expression of CTNNB1 mRNA] CTD PMID:17170073 all-trans-retinoic acid multiple interactions ISO RGD:733705 6480464 Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of CTNNB1 protein], Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein] CTD PMID:30093655 all-trans-retinoic acid decreases expression ISO RGD:733705 6480464 Tretinoin results in decreased expression of CTNNB1 mRNA, Tretinoin results in decreased expression of CTNNB1 protein CTD PMID:21924320 , PMID:30093655 all-trans-retinoic acid decreases expression ISO RGD:1550466 6480464 Tretinoin results in decreased expression of CTNNB1 protein CTD PMID:17064353 all-trans-retinoic acid increases expression ISO RGD:1550466 6480464 Tretinoin results in increased expression of CTNNB1 mRNA CTD PMID:16236135 all-trans-retinoic acid increases expression ISO RGD:733705 6480464 Tretinoin results in increased expression of CTNNB1 protein CTD PMID:17219422 all-trans-retinol multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Vitamin A results in decreased expression of CTNNB1 protein] more ... CTD PMID:17219422 all-trans-retinol decreases expression ISO RGD:733705 6480464 Vitamin A results in decreased expression of CTNNB1 protein CTD PMID:17219422 ammonia affects metabolic processing ISO RGD:1550466 6480464 CTNNB1 protein affects the metabolism of Ammonia CTD PMID:16557553 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CTNNB1 mRNA CTD PMID:16483693 ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of CTNNB1 protein CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of CTNNB1 protein CTD PMID:16144542 arecoline multiple interactions ISO RGD:1550466 6480464 [Arecoline co-treated with 4-nitroquinolone-1-oxide] results in increased expression of CTNNB1 protein CTD PMID:26464283 aristolochic acid multiple interactions ISO RGD:733705 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of CTNNB1 protein, BMP7 protein inhibits the reaction [[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CTNNB1 protein] CTD PMID:25663515 Aroclor 1254 decreases expression ISO RGD:1550466 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CTNNB1 mRNA CTD PMID:23650126 arsane multiple interactions ISO RGD:733705 6480464 Arsenic results in increased expression of and results in increased activity of CTNNB1 protein more ... CTD PMID:22552367 arsane increases expression ISO RGD:733705 6480464 Arsenic results in increased expression of CTNNB1 mRNA CTD PMID:29107899 arsane increases expression ISO RGD:1550466 6480464 Arsenic results in increased expression of CTNNB1 protein CTD PMID:22552367 arsenic atom multiple interactions ISO RGD:733705 6480464 Arsenic results in increased expression of and results in increased activity of CTNNB1 protein more ... CTD PMID:22552367 arsenic atom increases expression ISO RGD:733705 6480464 Arsenic results in increased expression of CTNNB1 mRNA CTD PMID:29107899 arsenic atom increases expression ISO RGD:1550466 6480464 Arsenic results in increased expression of CTNNB1 protein CTD PMID:22552367 arsenic trichloride increases expression ISO RGD:733705 6480464 arsenic trichloride results in increased expression of CTNNB1 protein CTD PMID:21854796 arsenic trichloride multiple interactions ISO RGD:733705 6480464 CAT protein inhibits the reaction [arsenic trichloride results in increased activity of CTNNB1 protein], CAT protein inhibits the reaction [arsenic trichloride results in increased expression of CTNNB1 protein] CTD PMID:21854796 arsenic trichloride increases activity ISO RGD:733705 6480464 arsenic trichloride results in increased activity of CTNNB1 protein CTD PMID:21854796 arsenite(3-) affects localization ISO RGD:733705 6480464 arsenite affects the localization of CTNNB1 protein CTD PMID:17400267 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of CTNNB1 protein CTD PMID:21344382 arsenite(3-) multiple interactions ISO RGD:733705 6480464 RTKI cpd inhibits the reaction [arsenite affects the localization of CTNNB1 protein] CTD PMID:17400267 arsenite(3-) decreases phosphorylation ISO RGD:733705 6480464 arsenite results in decreased phosphorylation of CTNNB1 protein CTD PMID:17400267 arsenous acid multiple interactions ISO RGD:733705 6480464 [Arsenic Trioxide binds to PIN1 protein] affects the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein] more ... CTD PMID:18485479 more ... arsenous acid increases cleavage ISO RGD:733705 6480464 Arsenic Trioxide results in increased cleavage of CTNNB1 protein CTD PMID:12181429 arsenous acid decreases expression ISO RGD:733705 6480464 Arsenic Trioxide results in decreased expression of CTNNB1 mRNA, Arsenic Trioxide results in decreased expression of CTNNB1 protein CTD PMID:17512576 more ... arsenous acid increases expression ISO RGD:733705 6480464 Arsenic Trioxide results in increased expression of CTNNB1 mRNA CTD PMID:20458559 artesunate multiple interactions EXP 6480464 artesunate inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of CTNNB1 protein] CTD PMID:29031619 atropine multiple interactions ISO RGD:733705 6480464 Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein mutant form], Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein] CTD PMID:17390078 auraptene decreases expression EXP 6480464 aurapten results in decreased expression of CTNNB1 protein mutant form CTD PMID:16012713 benzene multiple interactions ISO RGD:1550466 6480464 Benzene results in increased expression of and results in decreased phosphorylation of CTNNB1 protein, PPP2R1A protein affects the reaction [Benzene results in increased expression of and results in decreased phosphorylation of CTNNB1 protein] CTD PMID:30567741 benzo[a]pyrene increases expression ISO RGD:1550466 6480464 Benzo(a)pyrene results in increased expression of CTNNB1 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:733705 6480464 Benzo(a)pyrene metabolite results in increased expression of CTNNB1 mRNA, Benzo(a)pyrene results in increased expression of CTNNB1 mRNA CTD PMID:21714911 , PMID:26314263 berberine increases expression ISO RGD:733705 6480464 Berberine results in increased expression of CTNNB1 protein CTD PMID:26478571 berberine multiple interactions ISO RGD:733705 6480464 CTNNB1 mutant form inhibits the reaction [Berberine results in increased expression of BGLAP protein] more ... CTD PMID:26478571 beta-naphthoflavone multiple interactions ISO RGD:1550466 6480464 CTNNB1 gene mutant form affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA], CTNNB1 gene mutant form inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] CTD PMID:25174530 betulinic acid decreases expression ISO RGD:733705 6480464 betulinic acid results in decreased expression of CTNNB1 protein CTD PMID:30136359 betulinic acid multiple interactions ISO RGD:733705 6480464 [betulinic acid co-treated with Erlotinib Hydrochloride] results in decreased expression of CTNNB1 protein CTD PMID:30136359 bis(2-ethylhexyl) phthalate affects localization ISO RGD:1550466 6480464 Diethylhexyl Phthalate affects the localization of CTNNB1 protein CTD PMID:20307648 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and affects the localization of CTNNB1 protein], Diethylhexyl Phthalate results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:29940330 bis(2-ethylhexyl) phthalate increases expression ISO RGD:733705 6480464 Diethylhexyl Phthalate results in increased expression of CTNNB1 protein CTD PMID:30944277 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1550466 6480464 Diethylhexyl Phthalate results in increased expression of CTNNB1 mRNA CTD PMID:26219507 , PMID:27495896 bisphenol A decreases expression ISO RGD:733705 6480464 bisphenol A results in decreased expression of CTNNB1 protein CTD PMID:26922907 , PMID:30303745 bisphenol A affects expression ISO RGD:733705 6480464 bisphenol A affects the expression of CTNNB1 mRNA CTD PMID:30903817 bisphenol A decreases methylation ISO RGD:1550466 6480464 bisphenol A results in decreased methylation of CTNNB1 promoter CTD PMID:27312807 bisphenol A multiple interactions ISO RGD:733705 6480464 [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of CTNNB1 protein more ... CTD PMID:24532171 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CTNNB1 mRNA, bisphenol A results in decreased expression of CTNNB1 protein CTD PMID:19497385 more ... bisphenol A multiple interactions EXP 6480464 [Estradiol co-treated with bisphenol A] results in decreased expression of CTNNB1 mRNA more ... CTD PMID:25381574 more ... bisphenol A affects localization EXP 6480464 bisphenol A affects the localization of CTNNB1 protein CTD PMID:25381574 bisphenol A affects localization ISO RGD:1550466 6480464 bisphenol A affects the localization of CTNNB1 protein CTD PMID:26063408 bisphenol A decreases expression ISO RGD:1550466 6480464 bisphenol A results in decreased expression of CTNNB1 mRNA, bisphenol A results in decreased expression of CTNNB1 protein CTD PMID:23900028 more ... bisphenol F multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CTNNB1 mRNA CTD PMID:28628672 boric acid multiple interactions ISO RGD:1550466 6480464 boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein] more ... CTD PMID:28285642 bortezomib multiple interactions ISO RGD:733705 6480464 2-methoxyestradiol inhibits the reaction [CTNNB1 protein results in decreased susceptibility to Bortezomib] more ... CTD PMID:18485479 , PMID:19100720 bortezomib decreases response to substance ISO RGD:733705 6480464 CTNNB1 protein results in decreased susceptibility to Bortezomib CTD PMID:18485479 bortezomib increases expression ISO RGD:733705 6480464 Bortezomib results in increased expression of CTNNB1 protein CTD PMID:18485479 , PMID:19100720 bosutinib affects localization ISO RGD:733705 6480464 bosutinib affects the localization of CTNNB1 protein CTD PMID:16489032 bosutinib decreases phosphorylation ISO RGD:733705 6480464 bosutinib results in decreased phosphorylation of CTNNB1 protein CTD PMID:16489032 bosutinib multiple interactions ISO RGD:733705 6480464 bosutinib inhibits the reaction [CTNNB1 protein binds to TCF4 protein] more ... CTD PMID:16489032 brazilein decreases expression ISO RGD:733705 6480464 brazilein results in decreased expression of CTNNB1 protein CTD PMID:23948132 bromocriptine multiple interactions ISO RGD:1550466 6480464 [Bromocriptine co-treated with Estradiol] results in decreased expression of CTNNB1 protein CTD PMID:11786374 bucladesine increases phosphorylation EXP 6480464 Bucladesine results in increased phosphorylation of CTNNB1 protein CTD PMID:26964897 butylated hydroxyanisole multiple interactions ISO RGD:1550466 6480464 CTNNB1 gene mutant form inhibits the reaction [Butylated Hydroxyanisole results in increased expression of CYP1A1 mRNA], CTNNB1 gene mutant form inhibits the reaction [Butylated Hydroxyanisole results in increased expression of CYP1A2 mRNA] CTD PMID:25174530 Butylbenzyl phthalate multiple interactions ISO RGD:733705 6480464 HDAC6 mutant form inhibits the reaction [butylbenzyl phthalate affects the localization of CTNNB1 protein], trichostatin A inhibits the reaction [butylbenzyl phthalate affects the localization of CTNNB1 protein] CTD PMID:22552774 Butylbenzyl phthalate increases acetylation ISO RGD:1550466 6480464 butylbenzyl phthalate results in increased acetylation of CTNNB1 protein CTD PMID:27923775 Butylbenzyl phthalate affects localization ISO RGD:733705 6480464 butylbenzyl phthalate affects the localization of CTNNB1 protein CTD PMID:22552774 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of CTNNB1 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO RGD:733705 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in increased expression of and results in increased activity of CTNNB1 protein] more ... CTD PMID:22884995 , PMID:24798214 cadmium atom increases activity ISO RGD:733705 6480464 Cadmium results in increased activity of CTNNB1 protein CTD PMID:22884995 cadmium atom affects localization ISO RGD:733705 6480464 Cadmium affects the localization of CTNNB1 protein CTD PMID:24798214 cadmium atom affects localization EXP 6480464 Cadmium affects the localization of CTNNB1 protein CTD PMID:23080431 cadmium dichloride affects localization EXP 6480464 Cadmium Chloride affects the localization of CTNNB1 protein CTD PMID:20459685 cadmium dichloride increases expression ISO RGD:733705 6480464 Cadmium Chloride results in increased expression of CTNNB1 mRNA, Cadmium Chloride results in increased expression of CTNNB1 protein CTD PMID:26472689 , PMID:28527916 cadmium dichloride affects localization ISO RGD:733705 6480464 Cadmium Chloride affects the localization of CTNNB1 protein CTD PMID:24532171 cadmium dichloride multiple interactions ISO RGD:1550466 6480464 Cadmium Chloride results in increased phosphorylation of and affects the localization of CTNNB1 protein CTD PMID:19818801 cadmium dichloride decreases activity ISO RGD:1550466 6480464 Cadmium Chloride results in decreased activity of CTNNB1 protein CTD PMID:19818801 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CTNNB1 protein CTD PMID:15618353 cadmium dichloride affects expression ISO RGD:1550466 6480464 Cadmium Chloride affects the expression of CTNNB1 mRNA CTD PMID:18974090 cadmium dichloride multiple interactions EXP 6480464 Cadmium Chloride inhibits the reaction [CTNNB1 protein binds to CDH1 protein binds to CTNNA1 protein] more ... CTD PMID:15618353 more ... caffeine increases mutagenesis EXP 6480464 Caffeine results in increased mutagenesis of CTNNB1 gene CTD PMID:18283038 caffeine multiple interactions EXP 6480464 Caffeine inhibits the reaction [Doxorubicin results in decreased expression of CTNNB1 protein] CTD PMID:30377735 calciol multiple interactions ISO RGD:1550466 6480464 [Cholecalciferol co-treated with Tretinoin] affects the localization of CTNNB1 protein more ... CTD PMID:17170073 calciol increases expression ISO RGD:1550466 6480464 Cholecalciferol results in increased expression of CTNNB1 mRNA CTD PMID:17170073 calcitriol multiple interactions ISO RGD:733705 6480464 [Calcitriol binds to VDR protein] which results in decreased activity of CTNNB1 mRNA more ... CTD PMID:16051482 , PMID:20043299 calcitriol decreases activity ISO RGD:733705 6480464 Calcitriol results in decreased activity of CTNNB1 protein CTD PMID:16051482 calcium atom increases expression ISO RGD:733705 6480464 Calcium results in increased expression of CTNNB1 mRNA, Calcium results in increased expression of CTNNB1 protein CTD PMID:24658506 calcium atom multiple interactions ISO RGD:733705 6480464 CTNNB1 mutant form inhibits the reaction [Calcium results in increased expression of KRT1 mRNA] more ... CTD PMID:24658506 calcium(0) multiple interactions ISO RGD:733705 6480464 CTNNB1 mutant form inhibits the reaction [Calcium results in increased expression of KRT1 mRNA] more ... CTD PMID:24658506 calcium(0) increases expression ISO RGD:733705 6480464 Calcium results in increased expression of CTNNB1 mRNA, Calcium results in increased expression of CTNNB1 protein CTD PMID:24658506 calyculin a increases phosphorylation ISO RGD:733705 6480464 calyculin A results in increased phosphorylation of CTNNB1 protein CTD PMID:12813129 , PMID:16878161 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of CTNNB1 protein CTD PMID:22150557 capsaicin multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein] more ... CTD PMID:22150557 carbamazepine affects expression ISO RGD:733705 6480464 Carbamazepine affects the expression of CTNNB1 mRNA CTD PMID:24752500 celecoxib affects localization ISO RGD:733705 6480464 Celecoxib affects the localization of CTNNB1 protein, Celecoxib analog affects the localization of CTNNB1 protein CTD PMID:19682443 CGS-21680 affects localization ISO RGD:733705 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine affects the localization of CTNNB1 protein modified form CTD PMID:27595240 CGS-21680 multiple interactions ISO RGD:733705 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in increased expression of and affects the phosphorylation of CTNNB1 protein, CTNNB1 protein affects the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in increased expression of COL3A1 protein] CTD PMID:27595240 CHIR 99021 increases expression ISO RGD:733705 6480464 Chir 99021 results in increased expression of CTNNB1 protein CTD PMID:26259606 CHIR 99021 affects localization ISO RGD:1550466 6480464 Chir 99021 affects the localization of CTNNB1 protein CTD PMID:32220932 CHIR 99021 multiple interactions ISO RGD:733705 6480464 Chir 99021 inhibits the reaction [pristimerin results in decreased expression of CTNNB1 protein] CTD PMID:31715269 chitosan multiple interactions EXP 6480464 [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of CTNNB1 protein] CTD PMID:28732690 chlordecone decreases expression ISO RGD:733705 6480464 Chlordecone results in decreased expression of CTNNB1 protein CTD PMID:11695219 chlorohydrocarbon increases expression ISO RGD:733705 6480464 Hydrocarbons, Chlorinated analog results in increased expression of CTNNB1 protein CTD PMID:24355586 chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [Dibutyl Phthalate results in increased expression of CTNNB1 mRNA] CTD PMID:30053495 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of CTNNB1 mRNA CTD PMID:20691718 chromium(6+) multiple interactions ISO RGD:733705 6480464 CAT protein inhibits the reaction [chromium hexavalent ion results in increased expression of and results in increased activity of CTNNB1 protein] more ... CTD PMID:22552367 , PMID:27323401 chromium(6+) increases activity ISO RGD:733705 6480464 chromium hexavalent ion results in increased activity of CTNNB1 protein CTD PMID:27323401 chromium(6+) decreases expression ISO RGD:733705 6480464 chromium hexavalent ion results in decreased expression of CTNNB1 protein CTD PMID:23518002 chromium(6+) increases expression ISO RGD:1550466 6480464 chromium hexavalent ion results in increased expression of CTNNB1 protein CTD PMID:22552367 chrysin multiple interactions ISO RGD:733705 6480464 chrysin inhibits the reaction [Topotecan results in increased cleavage of CTNNB1 protein] CTD PMID:20457140 chrysin 5,7-dimethyl ether multiple interactions EXP 6480464 5 more ... CTD PMID:21554863 cisplatin decreases expression ISO RGD:1550466 6480464 Cisplatin results in decreased expression of CTNNB1 mRNA, Cisplatin results in decreased expression of CTNNB1 protein CTD PMID:23628706 , PMID:29148169 cisplatin multiple interactions ISO RGD:733705 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of CTNNB1 mRNA, [NEAT1 protein affects the susceptibility to Cisplatin] which affects the expression of and affects the phosphorylation of CTNNB1 protein CTD PMID:30291867 , PMID:30871063 cisplatin multiple interactions EXP 6480464 wogonin inhibits the reaction [Cisplatin results in increased expression of CTNNB1 protein] CTD PMID:31103702 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of CTNNB1 protein CTD PMID:31103702 cisplatin decreases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased susceptibility to Cisplatin CTD PMID:24560772 cisplatin increases phosphorylation ISO RGD:1550466 6480464 Cisplatin results in increased phosphorylation of CTNNB1 protein CTD PMID:24560772 cisplatin increases expression ISO RGD:733705 6480464 Cisplatin results in increased expression of CTNNB1 protein CTD PMID:20074550 cisplatin decreases localization ISO RGD:1550466 6480464 Cisplatin results in decreased localization of CTNNB1 protein CTD PMID:21745194 cisplatin multiple interactions ISO RGD:1550466 6480464 8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate inhibits the reaction [Cisplatin results in decreased localization of CTNNB1 protein] more ... CTD PMID:21745194 , PMID:24560772 cisplatin decreases response to substance ISO RGD:733705 6480464 CTNNB1 results in decreased susceptibility to Cisplatin CTD PMID:22000491 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of CTNNB1 mRNA CTD PMID:17602206 clozapine increases expression EXP 6480464 Clozapine results in increased expression of CTNNB1 protein CTD PMID:16144542 clozapine multiple interactions EXP 6480464 DRD2 protein affects the reaction [Clozapine results in increased expression of CTNNB1 protein] CTD PMID:16144542 cobalt dichloride decreases expression ISO RGD:733705 6480464 cobaltous chloride results in decreased expression of CTNNB1 mRNA CTD PMID:19320972 cobalt dichloride increases expression ISO RGD:733705 6480464 cobaltous chloride results in increased expression of CTNNB1 mRNA CTD PMID:17553155 , PMID:26314263 cocaine affects expression EXP 6480464 Cocaine affects the expression of CTNNB1 mRNA CTD PMID:20187946 cocaine multiple interactions EXP 6480464 Cocaine deficiency promotes the reaction [SMARCA4 protein binds to CTNNB1 promoter] CTD PMID:27422367 corosolic acid increases degradation ISO RGD:733705 6480464 corosolic acid results in increased degradation of CTNNB1 protein CTD PMID:24566423 corticosterone multiple interactions ISO RGD:1550466 6480464 [Corticosterone results in increased phosphorylation of NDRG1 protein] promotes the reaction [NDRG1 protein binds to CTNNB1 protein], [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNB1 protein CTD PMID:21655274 cortisol increases localization ISO RGD:733705 6480464 Hydrocortisone results in increased localization of CTNNB1 protein CTD PMID:25763180 cortisol multiple interactions ISO RGD:733705 6480464 GGTI 298 inhibits the reaction [Hydrocortisone results in increased localization of CTNNB1 protein] CTD PMID:25763180 crocidolite asbestos affects expression ISO RGD:733705 6480464 Asbestos, Crocidolite affects the expression of CTNNB1 mRNA, Asbestos, Crocidolite affects the expression of CTNNB1 protein CTD PMID:17331233 , PMID:21570478 crocidolite asbestos multiple interactions ISO RGD:733705 6480464 Asbestos, Crocidolite results in increased phosphorylation of and affects the localization of CTNNB1 protein, TNF protein promotes the reaction [Asbestos, Crocidolite affects the localization of CTNNB1 protein] CTD PMID:24160326 Cryptotanshinone multiple interactions ISO RGD:733705 6480464 cryptotanshinone inhibits the reaction [Dinoprostone results in increased expression of CTNNB1 protein] CTD PMID:30208247 curcumin decreases expression ISO RGD:733705 6480464 Curcumin analog results in decreased expression of CTNNB1 mRNA more ... CTD PMID:17041101 more ... curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [bisphenol A results in decreased expression of CTNNB1 mRNA], Curcumin results in decreased phosphorylation of and affects the localization of CTNNB1 protein CTD PMID:25963729 curcumin decreases phosphorylation EXP 6480464 Curcumin results in decreased phosphorylation of CTNNB1 protein CTD PMID:25963729 curcumin increases expression EXP 6480464 Curcumin results in increased expression of CTNNB1 mRNA CTD PMID:25963729 curcumin decreases expression ISO RGD:1550466 6480464 Curcumin results in decreased expression of CTNNB1 protein CTD PMID:10783313 curcumin multiple interactions ISO RGD:733705 6480464 [piperine co-treated with Curcumin] results in decreased expression of CTNNB1 protein more ... CTD PMID:19294764 more ... curcumin increases degradation ISO RGD:733705 6480464 Curcumin analog results in increased degradation of CTNNB1 protein, Curcumin results in increased degradation of CTNNB1 protein CTD PMID:17041101 cycloheximide decreases expression ISO RGD:1550466 6480464 Cycloheximide results in decreased expression of CTNNB1 protein CTD PMID:27693619 cycloheximide multiple interactions ISO RGD:1550466 6480464 Phenobarbital affects the reaction [Cycloheximide results in decreased expression of CTNNB1 protein] CTD PMID:27693619 cyclosporin A decreases expression ISO RGD:1550466 6480464 Cyclosporine results in decreased expression of CTNNB1 protein CTD PMID:22416070 cyclosporin A decreases expression ISO RGD:733705 6480464 Cyclosporine results in decreased expression of CTNNB1 mRNA CTD PMID:20106945 , PMID:25562108 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of CTNNB1 mRNA, Glucose results in decreased expression of CTNNB1 protein CTD PMID:18004065 , PMID:21818840 D-glucose multiple interactions ISO RGD:733705 6480464 DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA], DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein] CTD PMID:29163160 D-glucose increases expression ISO RGD:733705 6480464 Glucose results in increased expression of CTNNB1 mRNA, Glucose results in increased expression of CTNNB1 protein CTD PMID:29163160 D-glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] CTD PMID:18004065 DDE increases activity ISO RGD:733705 6480464 Dichlorodiphenyl Dichloroethylene results in increased activity of CTNNB1 protein CTD PMID:27589886 DDE affects activity ISO RGD:733705 6480464 Dichlorodiphenyl Dichloroethylene affects the activity of CTNNB1 protein CTD PMID:25386960 DDE multiple interactions ISO RGD:733705 6480464 CTNNB1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of CCND1 protein], CTNNB1 affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of MYC protein] CTD PMID:25386960 DDT multiple interactions ISO RGD:733705 6480464 Acetylcysteine inhibits the reaction [DDT results in increased expression of and results in decreased phosphorylation of CTNNB1 protein] more ... CTD PMID:22902829 , PMID:24968063 DDT affects localization ISO RGD:733705 6480464 DDT affects the localization of CTNNB1 protein CTD PMID:24968063 DDT increases expression ISO RGD:733705 6480464 DDT results in increased expression of CTNNB1 protein CTD PMID:22902829 Deguelin decreases expression ISO RGD:733705 6480464 deguelin results in decreased expression of CTNNB1 protein CTD PMID:21472727 Deguelin increases degradation ISO RGD:733705 6480464 deguelin results in increased degradation of CTNNB1 protein CTD PMID:21472727 Deguelin multiple interactions ISO RGD:733705 6480464 [deguelin results in increased degradation of CTNNB1 protein] which results in decreased expression of CCND1 protein more ... CTD PMID:21472727 , PMID:22986522 delta-tocotrienol decreases expression ISO RGD:733705 6480464 tocotrienol, delta results in decreased expression of CTNNB1 protein CTD PMID:21453743 deoxynivalenol affects phosphorylation ISO RGD:1550466 6480464 deoxynivalenol affects the phosphorylation of CTNNB1 protein CTD PMID:23811945 desferrioxamine B multiple interactions ISO RGD:733705 6480464 Deferoxamine inhibits the reaction [ferumoxides results in increased activity of CTNNB1 protein] CTD PMID:20338187 dexamethasone decreases expression ISO RGD:1550466 6480464 Dexamethasone results in decreased expression of CTNNB1 protein CTD PMID:20578217 dexamethasone multiple interactions EXP 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of CTNNB1 protein] more ... CTD PMID:20501703 , PMID:29535048 dexamethasone affects localization EXP 6480464 Dexamethasone affects the localization of CTNNB1 protein CTD PMID:20501703 dexamethasone multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CTNNB1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CTNNB1 mRNA CTD PMID:28628672 dexamethasone multiple interactions ISO RGD:1550466 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in decreased expression of CTNNB1 protein more ... CTD PMID:28285642 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CTNNB1 mRNA, Dexamethasone results in decreased expression of CTNNB1 protein CTD PMID:18467435 , PMID:20501703 dextran sulfate increases expression ISO RGD:1550466 6480464 Dextran Sulfate results in increased expression of CTNNB1 protein CTD PMID:16049979 dextran sulfate multiple interactions ISO RGD:1550466 6480464 [2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:15459021 more ... diallyl disulfide increases expression ISO RGD:733705 6480464 diallyl disulfide results in increased expression of CTNNB1 mRNA, diallyl disulfide results in increased expression of CTNNB1 protein CTD PMID:20600798 diallyl disulfide decreases phosphorylation ISO RGD:733705 6480464 diallyl disulfide results in decreased phosphorylation of CTNNB1 protein CTD PMID:23663050 diallyl trisulfide increases cleavage ISO RGD:733705 6480464 diallyl trisulfide results in increased cleavage of CTNNB1 protein CTD PMID:22578287 diallyl trisulfide decreases expression ISO RGD:733705 6480464 diallyl trisulfide results in decreased expression of CTNNB1 protein CTD PMID:29626521 diallyl trisulfide multiple interactions ISO RGD:733705 6480464 diallyl trisulfide inhibits the reaction [CTNNB1 protein results in decreased expression of CDKN1A protein] more ... CTD PMID:29626521 diallyl trisulfide decreases phosphorylation ISO RGD:733705 6480464 diallyl trisulfide results in decreased phosphorylation of CTNNB1 protein CTD PMID:23663050 diarsenic trioxide multiple interactions ISO RGD:733705 6480464 [Arsenic Trioxide binds to PIN1 protein] affects the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein] more ... CTD PMID:18485479 more ... diarsenic trioxide decreases expression ISO RGD:733705 6480464 Arsenic Trioxide results in decreased expression of CTNNB1 mRNA, Arsenic Trioxide results in decreased expression of CTNNB1 protein CTD PMID:17512576 more ... diarsenic trioxide increases expression ISO RGD:733705 6480464 Arsenic Trioxide results in increased expression of CTNNB1 mRNA CTD PMID:20458559 diarsenic trioxide increases cleavage ISO RGD:733705 6480464 Arsenic Trioxide results in increased cleavage of CTNNB1 protein CTD PMID:12181429 diazoxide multiple interactions ISO RGD:733705 6480464 Diazoxide inhibits the reaction [CTNNB1 protein results in increased activity of CCND1 promoter] CTD PMID:19052819 diazoxide decreases expression ISO RGD:733705 6480464 Diazoxide results in decreased expression of CTNNB1 protein CTD PMID:19052819 dibutyl phthalate affects localization ISO RGD:733705 6480464 Dibutyl Phthalate affects the localization of CTNNB1 protein CTD PMID:22552774 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CTNNB1 mRNA, Dibutyl Phthalate results in increased expression of CTNNB1 protein CTD PMID:30053495 dibutyl phthalate multiple interactions EXP 6480464 Chloroquine inhibits the reaction [Dibutyl Phthalate results in increased expression of CTNNB1 mRNA], Sirolimus promotes the reaction [Dibutyl Phthalate results in increased expression of CTNNB1 mRNA] CTD PMID:30053495 dibutyl phthalate multiple interactions ISO RGD:733705 6480464 HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate affects the localization of CTNNB1 protein], trichostatin A inhibits the reaction [Dibutyl Phthalate affects the localization of CTNNB1 protein] CTD PMID:22552774 dichloromethane increases mutagenesis ISO RGD:1550466 6480464 Methylene Chloride results in increased mutagenesis of CTNNB1 gene CTD PMID:10467420 diclofenac affects expression ISO RGD:733705 6480464 Diclofenac affects the expression of CTNNB1 mRNA CTD PMID:24752500 dicrotophos decreases expression ISO RGD:733705 6480464 dicrotophos results in decreased expression of CTNNB1 mRNA CTD PMID:28302478 diethylstilbestrol increases expression ISO RGD:1550466 6480464 Diethylstilbestrol results in increased expression of CTNNB1 mRNA CTD PMID:14648872 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of CTNNB1 protein CTD PMID:26911934 dimethyl sulfoxide increases expression ISO RGD:733705 6480464 Dimethyl Sulfoxide results in increased expression of CTNNB1 protein CTD PMID:20091315 dioscin increases expression ISO RGD:1550466 6480464 dioscin results in increased expression of CTNNB1 mRNA, dioscin results in increased expression of CTNNB1 protein CTD PMID:24742230 dioscin multiple interactions ISO RGD:1550466 6480464 fulvestrant inhibits the reaction [dioscin results in increased expression of CTNNB1 mRNA] CTD PMID:24742230 dioscin increases expression ISO RGD:733705 6480464 dioscin results in increased expression of CTNNB1 protein CTD PMID:24742230 diosgenin decreases expression ISO RGD:1550466 6480464 Diosgenin results in decreased expression of CTNNB1 mRNA CTD PMID:26408789 dioxygen multiple interactions ISO RGD:1550466 6480464 [Butylated Hydroxytoluene co-treated with Oxygen] affects the localization of CTNNB1 protein, [Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of CTNNB1 protein CTD PMID:16272459 dioxygen affects localization ISO RGD:733705 6480464 Oxygen deficiency affects the localization of CTNNB1 protein CTD PMID:25297617 dioxygen multiple interactions ISO RGD:733705 6480464 [amurensin G results in decreased activity of SIRT1 protein] inhibits the reaction [Oxygen deficiency results in decreased expression of CTNNB1] more ... CTD PMID:22245592 , PMID:25297617 dioxygen decreases acetylation ISO RGD:733705 6480464 Oxygen deficiency results in decreased acetylation of CTNNB1 protein CTD PMID:22245592 dioxygen decreases expression ISO RGD:733705 6480464 Oxygen deficiency results in decreased expression of CTNNB1 mRNA CTD PMID:17175027 disodium cromoglycate multiple interactions EXP 6480464 [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of CTNNB1 protein] CTD PMID:28732690 diuron increases expression EXP 6480464 Diuron results in increased expression of CTNNB1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:733705 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases response to substance ISO RGD:1550466 6480464 CTNNB1 gene mutant form results in decreased susceptibility to Doxorubicin CTD PMID:20237062 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CTNNB1 protein CTD PMID:30377735 doxorubicin multiple interactions EXP 6480464 Caffeine inhibits the reaction [Doxorubicin results in decreased expression of CTNNB1 protein] more ... CTD PMID:30377735 doxorubicin increases expression ISO RGD:733705 6480464 Doxorubicin results in increased expression of CTNNB1 mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:733705 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] more ... CTD PMID:19047049 doxorubicin decreases phosphorylation ISO RGD:733705 6480464 Doxorubicin results in decreased phosphorylation of CTNNB1 protein CTD PMID:23956100 doxorubicin increases expression ISO RGD:1550466 6480464 Doxorubicin results in increased expression of CTNNB1 protein CTD PMID:20237062 eckol decreases expression ISO RGD:733705 6480464 eckol results in decreased expression of CTNNB1 protein CTD PMID:21514314 endosulfan multiple interactions ISO RGD:733705 6480464 Endosulfan inhibits the reaction [CDH1 protein binds to CTNNB1 protein], Endosulfan results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:22677888 , PMID:22902829 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of CTNNB1 protein CTD PMID:26911934 endosulfan decreases expression ISO RGD:733705 6480464 Endosulfan results in decreased expression of CTNNB1 protein CTD PMID:28108160 erlotinib hydrochloride multiple interactions ISO RGD:733705 6480464 [betulinic acid co-treated with Erlotinib Hydrochloride] results in decreased expression of CTNNB1 protein CTD PMID:30136359 erlotinib hydrochloride decreases expression ISO RGD:733705 6480464 Erlotinib Hydrochloride results in decreased expression of CTNNB1 protein CTD PMID:30136359 Estradiol dipropionate multiple interactions ISO RGD:1550466 6480464 [estradiol dipropionate co-treated with Butyrates] results in decreased expression of CTNNB1 protein, [estradiol dipropionate co-treated with trichostatin A] results in decreased expression of CTNNB1 protein CTD PMID:15930180 ethanol multiple interactions ISO RGD:733705 6480464 Ethanol results in increased expression of and affects the localization of CTNNB1 protein more ... CTD PMID:26014148 , PMID:30567741 ethanol multiple interactions ISO RGD:1550466 6480464 Ethanol affects the expression of and affects the splicing of CTNNB1 mRNA CTD PMID:30319688 ethanol multiple interactions EXP 6480464 Ethanol affects the reaction [Dietary Fats affects the expression of CTNNB1 mRNA], Ethanol affects the reaction [Dietary Fats affects the expression of CTNNB1 protein] CTD PMID:31811911 ethanol affects localization ISO RGD:733705 6480464 Ethanol affects the localization of CTNNB1 protein CTD PMID:30567741 ethanol affects response to substance ISO RGD:733705 6480464 CTNNB1 gene mutant form affects the susceptibility to Ethanol CTD PMID:25822088 ethosuximide multiple interactions EXP 6480464 Ethosuximide inhibits the reaction [APP protein modified form results in decreased expression of CTNNB1 mRNA] CTD PMID:26420483 ethosuximide increases expression EXP 6480464 Ethosuximide results in increased expression of CTNNB1 mRNA CTD PMID:26420483 ethosuximide decreases phosphorylation EXP 6480464 Ethosuximide results in decreased phosphorylation of CTNNB1 protein CTD PMID:26420483 ethosuximide multiple interactions ISO RGD:733705 6480464 DKK1 protein inhibits the reaction [Ethosuximide results in decreased phosphorylation of CTNNB1 protein] CTD PMID:26420483 etoposide multiple interactions ISO RGD:733705 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein] more ... CTD PMID:19047049 eugenol decreases expression ISO RGD:1550466 6480464 Eugenol results in decreased expression of CTNNB1 mRNA CTD PMID:31926151 eugenol decreases expression ISO RGD:733705 6480464 Eugenol results in decreased expression of CTNNB1 mRNA CTD PMID:31926151 eugenol multiple interactions ISO RGD:1550466 6480464 Eugenol results in decreased expression of and affects the phosphorylation of and affects the localization of CTNNB1 protein CTD PMID:31926151 eugenol multiple interactions ISO RGD:733705 6480464 Eugenol results in decreased expression of and affects the phosphorylation of and affects the localization of CTNNB1 protein CTD PMID:31926151 famotidine multiple interactions ISO RGD:733705 6480464 Famotidine inhibits the reaction [Dizocilpine Maleate results in decreased expression of CTNNB1 mRNA] CTD PMID:31563592 famotidine increases expression ISO RGD:733705 6480464 Famotidine results in increased expression of CTNNB1 mRNA CTD PMID:31563592 fisetin decreases expression ISO RGD:733705 6480464 fisetin results in decreased expression of CTNNB1 protein CTD PMID:30802432 fisetin multiple interactions ISO RGD:733705 6480464 fisetin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CTNNB1 protein] CTD PMID:31606474 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of CTNNB1 mRNA CTD PMID:23238999 flavonoids multiple interactions EXP 6480464 DKK1 protein inhibits the reaction [Flavonoids results in increased expression of CTNNB1 mRNA] CTD PMID:23238999 fluoxetine multiple interactions EXP 6480464 [Fluoxetine co-treated with Ketanserin] results in increased expression of CTNNB1 mRNA, Fluoxetine inhibits the reaction [Monocrotaline results in decreased expression of CTNNB1 protein] CTD PMID:21619414 , PMID:21627639 flutamide affects localization ISO RGD:733705 6480464 Flutamide analog affects the localization of CTNNB1 protein CTD PMID:21111724 folic acid affects expression ISO RGD:733705 6480464 Folic Acid affects the expression of CTNNB1 mRNA CTD PMID:16361273 folic acid decreases expression ISO RGD:733705 6480464 Folic Acid deficiency results in decreased expression of CTNNB1 protein CTD PMID:28639913 folic acid multiple interactions ISO RGD:1550466 6480464 [1 more ... CTD PMID:22206623 , PMID:22959928 formaldehyde decreases expression ISO RGD:733705 6480464 Formaldehyde results in decreased expression of CTNNB1 mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:1550466 6480464 fulvestrant inhibits the reaction [dioscin results in increased expression of CTNNB1 mRNA] CTD PMID:24742230 fumonisin B1 increases expression ISO RGD:1550466 6480464 fumonisin B1 results in increased expression of CTNNB1 mRNA CTD PMID:16221962 geldanamycin multiple interactions ISO RGD:733705 6480464 geldanamycin promotes the reaction [CDH1 protein binds to CTNNB1 protein], IL24 protein promotes the reaction [geldanamycin promotes the reaction [CDH1 protein binds to CTNNB1 protein]] CTD PMID:17024233 gemcitabine increases expression ISO RGD:733705 6480464 gemcitabine results in increased expression of CTNNB1 mRNA CTD PMID:25605917 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of CTNNB1 protein CTD PMID:16443925 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CTNNB1 mRNA CTD PMID:22061828 geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CTNNB1 mRNA] more ... CTD PMID:26165751 , PMID:28428697 gingerol affects localization ISO RGD:733705 6480464 gingerol affects the localization of CTNNB1 protein CTD PMID:18058799 gingerol increases expression ISO RGD:1550466 6480464 gingerol results in increased expression of CTNNB1 mRNA CTD PMID:26498061 gingerol multiple interactions ISO RGD:1550466 6480464 gingerol results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:26498061 gingerol multiple interactions ISO RGD:733705 6480464 gingerol promotes the reaction [IL1B protein results in increased expression of CTNNB1 protein] CTD PMID:27645308 glucose decreases expression EXP 6480464 Glucose results in decreased expression of CTNNB1 mRNA, Glucose results in decreased expression of CTNNB1 protein CTD PMID:18004065 , PMID:21818840 glucose increases expression ISO RGD:733705 6480464 Glucose results in increased expression of CTNNB1 mRNA, Glucose results in increased expression of CTNNB1 protein CTD PMID:29163160 glucose multiple interactions ISO RGD:733705 6480464 DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA], DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein] CTD PMID:29163160 glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] CTD PMID:18004065 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of CTNNB1 protein CTD PMID:28780397 haloperidol multiple interactions EXP 6480464 DRD2 protein affects the reaction [Haloperidol results in increased expression of CTNNB1 protein] CTD PMID:16144542 haloperidol decreases expression ISO RGD:1550466 6480464 Haloperidol results in decreased expression of CTNNB1 mRNA CTD PMID:18797397 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of CTNNB1 protein CTD PMID:16144542 heparin multiple interactions EXP 6480464 Heparin promotes the reaction [Doxorubicin results in decreased expression of CTNNB1 protein], Lithium Chloride inhibits the reaction [Heparin promotes the reaction [Doxorubicin results in decreased expression of CTNNB1 protein]] CTD PMID:30377735 heptachlor multiple interactions ISO RGD:733705 6480464 Heptachlor inhibits the reaction [CDH1 protein binds to CTNNB1 protein] CTD PMID:22902829 heptachlor increases expression ISO RGD:733705 6480464 Heptachlor results in increased expression of CTNNB1 protein CTD PMID:22902829 hexachlorophene multiple interactions ISO RGD:733705 6480464 Hexachlorophene inhibits the reaction [Lithium Chloride results in increased expression of CTNNB1 protein] more ... CTD PMID:16735606 hexachlorophene increases degradation ISO RGD:733705 6480464 Hexachlorophene results in increased degradation of CTNNB1 protein CTD PMID:16735606 hyaluronic acid multiple interactions ISO RGD:733705 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of ABCB1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] more ... CTD PMID:19047049 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of CTNNB1 protein CTD PMID:16204253 hydrogen peroxide multiple interactions ISO RGD:733705 6480464 Hydrogen Peroxide inhibits the reaction [CDH5 protein binds to CTNNB1 protein], naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of CTNNB1 protein] CTD PMID:24211779 , PMID:26482937 hydrogen peroxide multiple interactions EXP 6480464 pirinixic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of CTNNB1 protein], pirinixic acid inhibits the reaction [Hydrogen Peroxide results in decreased stability of CTNNB1 protein] CTD PMID:16204253 hydrogen peroxide decreases expression ISO RGD:733705 6480464 Hydrogen Peroxide results in decreased expression of CTNNB1 mRNA, Hydrogen Peroxide results in decreased expression of CTNNB1 protein CTD PMID:12419474 , PMID:26482937 hydroquinone decreases expression ISO RGD:733705 6480464 hydroquinone results in decreased expression of CTNNB1 protein CTD PMID:28886972 hydroquinone affects localization ISO RGD:733705 6480464 hydroquinone affects the localization of CTNNB1 protein CTD PMID:30567741 hydroquinone multiple interactions ISO RGD:733705 6480464 hydroquinone inhibits the reaction [CTNNB1 protein binds to LEF1 protein] more ... CTD PMID:28886972 , PMID:30567741 hydroxyflutamide decreases phosphorylation ISO RGD:733705 6480464 hydroxyflutamide results in decreased phosphorylation of CTNNB1 protein CTD PMID:28163245 hydroxyflutamide multiple interactions ISO RGD:733705 6480464 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3 more ... CTD PMID:28163245 indometacin affects localization ISO RGD:733705 6480464 Indomethacin affects the localization of CTNNB1 protein CTD PMID:15963497 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of CTNNB1 protein CTD PMID:16818512 indometacin multiple interactions EXP 6480464 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester inhibits the reaction [Indomethacin results in increased expression of CTNNB1 protein], nitroaspirin inhibits the reaction [Indomethacin results in increased expression of CTNNB1 protein] CTD PMID:16818512 indometacin increases phosphorylation ISO RGD:733705 6480464 Indomethacin results in increased phosphorylation of CTNNB1 protein CTD PMID:12813129 indometacin decreases expression ISO RGD:733705 6480464 Indomethacin results in decreased expression of CTNNB1 mRNA, Indomethacin results in decreased expression of CTNNB1 protein CTD PMID:11756231 , PMID:15188006 indometacin multiple interactions ISO RGD:733705 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CTNNB1 mRNA more ... CTD PMID:11756231 more ... kaempferol multiple interactions EXP 6480464 kaempferol promotes the reaction [Sulindac inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of CTNNB1 protein]] CTD PMID:29999212 ketanserin multiple interactions EXP 6480464 [Fluoxetine co-treated with Ketanserin] results in increased expression of CTNNB1 mRNA CTD PMID:21627639 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and affects the localization of CTNNB1 protein], [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein] CTD PMID:29940330 lactacystin multiple interactions ISO RGD:733705 6480464 lactacystin inhibits the reaction [Indomethacin results in decreased expression of CTNNB1 protein], lactacystin inhibits the reaction [resveratrol results in increased degradation of CTNNB1 protein] CTD PMID:11756231 , PMID:26040106 lead diacetate increases phosphorylation EXP 6480464 lead acetate results in increased phosphorylation of CTNNB1 protein CTD PMID:24999626 lead diacetate multiple interactions ISO RGD:733705 6480464 WNT7A protein inhibits the reaction [lead acetate results in increased phosphorylation of CTNNB1 protein] CTD PMID:24999626 lead nitrate multiple interactions ISO RGD:1550466 6480464 [lead nitrate results in increased abundance of Lead] which results in decreased expression of and affects the localization of CTNNB1 protein more ... CTD PMID:30731080 lead(0) decreases expression ISO RGD:1550466 6480464 Lead results in decreased expression of CTNNB1 mRNA, Lead results in decreased expression of CTNNB1 protein CTD PMID:23086611 , PMID:26518054 lead(0) multiple interactions ISO RGD:1550466 6480464 [lead nitrate results in increased abundance of Lead] which results in decreased expression of and affects the localization of CTNNB1 protein more ... CTD PMID:30731080 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of CTNNB1 mRNA, Lead results in decreased expression of CTNNB1 protein CTD PMID:23086611 lead(2+) decreases expression ISO RGD:1550466 6480464 Lead results in decreased expression of CTNNB1 mRNA, Lead results in decreased expression of CTNNB1 protein CTD PMID:23086611 , PMID:26518054 lead(2+) multiple interactions ISO RGD:1550466 6480464 [lead nitrate results in increased abundance of Lead] which results in decreased expression of and affects the localization of CTNNB1 protein more ... CTD PMID:30731080 lead(2+) decreases expression EXP 6480464 Lead results in decreased expression of CTNNB1 mRNA, Lead results in decreased expression of CTNNB1 protein CTD PMID:23086611 leupeptin multiple interactions EXP 6480464 leupeptin inhibits the reaction [2 more ... CTD PMID:19464575 LGK974 multiple interactions ISO RGD:733705 6480464 LGK974 inhibits the reaction [Paraquat affects the localization of CTNNB1 protein], LGK974 inhibits the reaction [Paraquat results in increased expression of and results in decreased phosphorylation of CTNNB1 protein] CTD PMID:30205152 lipopolysaccharide increases expression ISO RGD:733705 6480464 Lipopolysaccharides results in increased expression of CTNNB1 protein CTD PMID:11739494 lithium atom increases expression ISO RGD:1550466 6480464 Lithium results in increased expression of CTNNB1 protein CTD PMID:19621015 lithium atom increases expression EXP 6480464 Lithium results in increased expression of CTNNB1 protein CTD PMID:12942141 , PMID:18296634 lithium atom decreases expression EXP 6480464 Lithium results in decreased expression of CTNNB1 mRNA CTD PMID:12942141 lithium atom multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA], Lithium results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:16288908 , PMID:19149911 lithium atom affects localization EXP 6480464 Lithium affects the localization of CTNNB1 protein CTD PMID:18296634 lithium chloride multiple interactions ISO RGD:733705 6480464 [Lithium Chloride co-treated with ESR1 protein] results in increased expression of CTNNB1 protein more ... CTD PMID:12813129 more ... lithium chloride increases expression EXP 6480464 Lithium Chloride results in increased expression of CTNNB1 mRNA CTD PMID:27045591 lithium chloride affects localization ISO RGD:733705 6480464 Lithium Chloride affects the localization of CTNNB1 protein, Lithium Chloride affects the localization of CTNNB1 protein modified form CTD PMID:22493441 more ... lithium chloride increases stability ISO RGD:1550466 6480464 Lithium Chloride results in increased stability of CTNNB1 protein CTD PMID:23326414 lithium chloride increases expression ISO RGD:1550466 6480464 Lithium Chloride results in increased expression of CTNNB1 mRNA, Lithium Chloride results in increased expression of CTNNB1 protein CTD PMID:22935447 more ... lithium chloride increases activity EXP 6480464 Lithium Chloride results in increased activity of CTNNB1 protein CTD PMID:20694829 lithium chloride increases expression ISO RGD:733705 6480464 Lithium Chloride results in increased expression of CTNNB1 mRNA, Lithium Chloride results in increased expression of CTNNB1 protein CTD PMID:16053526 more ... lithium chloride multiple interactions EXP 6480464 [[Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein] which affects the expression of GJA1 protein more ... CTD PMID:18972237 more ... lithium chloride increases localization ISO RGD:1550466 6480464 Lithium Chloride results in increased localization of CTNNB1 protein CTD PMID:19442631 lithium chloride increases activity ISO RGD:1550466 6480464 Lithium Chloride results in increased activity of CTNNB1 protein CTD PMID:19582394 , PMID:20118494 lithium chloride multiple interactions ISO RGD:1550466 6480464 [[Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased localization of CTNNB1 protein] which results in increased expression of GIP mRNA more ... CTD PMID:15364539 more ... lithium chloride decreases phosphorylation ISO RGD:733705 6480464 Lithium Chloride results in decreased phosphorylation of CTNNB1 protein CTD PMID:16076840 lithium hydride multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA], Lithium results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:16288908 , PMID:19149911 lithium hydride affects localization EXP 6480464 Lithium affects the localization of CTNNB1 protein CTD PMID:18296634 lithium hydride decreases expression EXP 6480464 Lithium results in decreased expression of CTNNB1 mRNA CTD PMID:12942141 lithium hydride increases expression ISO RGD:1550466 6480464 Lithium results in increased expression of CTNNB1 protein CTD PMID:19621015 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of CTNNB1 protein CTD PMID:12942141 , PMID:18296634 lithocholic acid multiple interactions ISO RGD:733705 6480464 [Lithocholic Acid binds to VDR protein] which results in decreased activity of CTNNB1 mRNA CTD PMID:20043299 losartan multiple interactions ISO RGD:1550466 6480464 Losartan inhibits the reaction [AGT protein affects the localization of CTNNB1 protein] more ... CTD PMID:28578904 losartan multiple interactions ISO RGD:733705 6480464 Losartan inhibits the reaction [AGT protein affects the localization of CTNNB1 protein] more ... CTD PMID:28578904 lovastatin decreases degradation EXP 6480464 Lovastatin results in decreased degradation of CTNNB1 protein CTD PMID:19741129 lovastatin increases expression ISO RGD:1550466 6480464 Lovastatin results in increased expression of CTNNB1 mRNA CTD PMID:24742230 lovastatin multiple interactions ISO RGD:733705 6480464 Lovastatin affects the localization of and results in increased expression of CTNNB1 protein CTD PMID:17234346 lupeol decreases expression ISO RGD:1550466 6480464 lupeol results in decreased expression of CTNNB1 protein CTD PMID:20979057 lupeol multiple interactions ISO RGD:733705 6480464 lupeol results in decreased localization of and results in decreased activity of CTNNB1 protein CTD PMID:20732907 luteolin decreases expression ISO RGD:733705 6480464 Luteolin results in decreased expression of CTNNB1 protein CTD PMID:32268164 LY-2157299 multiple interactions ISO RGD:1550466 6480464 [ABCB4 protein affects the susceptibility to LY-2157299] which affects the expression of CTNNB1 protein CTD PMID:29808285 LY294002 multiple interactions ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased stability of CTNNB1 protein] more ... CTD PMID:20542495 more ... LY294002 decreases expression ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CTNNB1 protein CTD PMID:23143138 LY294002 multiple interactions ISO RGD:733705 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in increased expression of and results in increased activity of CTNNB1 protein] more ... CTD PMID:19814765 more ... Magnolol multiple interactions EXP 6480464 magnolol inhibits the reaction [Monocrotaline results in increased expression of CTNNB1 protein] CTD PMID:30466619 manganese atom decreases expression ISO RGD:733705 6480464 Manganese results in decreased expression of CTNNB1 mRNA CTD PMID:17175027 manganese(0) decreases expression ISO RGD:733705 6480464 Manganese results in decreased expression of CTNNB1 mRNA CTD PMID:17175027 manganese(II) chloride decreases expression ISO RGD:733705 6480464 manganese chloride results in decreased expression of CTNNB1 mRNA CTD PMID:17175027 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of CTNNB1 protein CTD PMID:24464479 manganese(II) chloride multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [manganese chloride results in decreased expression of CTNNB1 protein] CTD PMID:24464479 mangiferin decreases response to substance ISO RGD:733705 6480464 CTNNB1 protein results in decreased susceptibility to mangiferin CTD PMID:23707762 Matrine decreases expression ISO RGD:733705 6480464 matrine results in decreased expression of CTNNB1 protein CTD PMID:31112718 MeIQ affects mutagenesis ISO RGD:1550466 6480464 2-amino-3 more ... CTD PMID:12893427 melatonin multiple interactions ISO RGD:733705 6480464 Melatonin inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to CTNNB1 promoter]] CTD PMID:26990689 menadione decreases expression ISO RGD:733705 6480464 Vitamin K 3 results in decreased expression of CTNNB1 protein CTD PMID:31238027 methamphetamine multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA] CTD PMID:19149911 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of CTNNB1 mRNA CTD PMID:19149911 , PMID:32035215 methotrexate multiple interactions ISO RGD:733705 6480464 Methotrexate promotes the reaction [6-bromoindirubin-3'-oxime results in decreased phosphorylation of CTNNB1 protein] CTD PMID:19727391 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of CTNNB1 protein CTD PMID:25187349 methotrexate multiple interactions EXP 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of CTNNB1 protein CTD PMID:25187349 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of CTNNB1 protein CTD PMID:16443925 methyl methanesulfonate decreases expression ISO RGD:733705 6480464 Methyl Methanesulfonate results in decreased expression of CTNNB1 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:733705 6480464 methylmercuric chloride results in increased expression of CTNNB1 mRNA CTD PMID:23179753 methylmercury chloride decreases expression ISO RGD:733705 6480464 methylmercuric chloride results in decreased expression of CTNNB1 mRNA CTD PMID:29581082 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of CTNNB1 protein CTD PMID:28526320 methylmercury(1+) increases expression ISO RGD:733705 6480464 methylmercury II results in increased expression of CTNNB1 mRNA CTD PMID:26314263 microcystin-LR increases ubiquitination ISO RGD:733705 6480464 cyanoginosin LR results in increased ubiquitination of CTNNB1 protein CTD PMID:20421190 mifepristone increases expression ISO RGD:733705 6480464 Mifepristone results in increased expression of CTNNB1 mRNA CTD PMID:17584828 ML-7 decreases expression ISO RGD:733705 6480464 ML 7 results in decreased expression of CTNNB1 protein CTD PMID:18710790 ML-7 affects localization ISO RGD:733705 6480464 ML 7 affects the localization of CTNNB1 protein CTD PMID:18710790 mono(2-ethylhexyl) phthalate increases expression ISO RGD:733705 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of CTNNB1 mRNA CTD PMID:22321834 mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein], mono-(2-ethylhexyl)phthalate results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:29940330 Monobutylphthalate affects expression EXP 6480464 monobutyl phthalate affects the expression of CTNNB1 mRNA CTD PMID:20864626 monocrotaline multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [Monocrotaline results in decreased expression of CTNNB1 protein], magnolol inhibits the reaction [Monocrotaline results in increased expression of CTNNB1 protein] CTD PMID:21619414 , PMID:30466619 monocrotaline increases expression EXP 6480464 Monocrotaline results in increased expression of CTNNB1 protein CTD PMID:30466619 monocrotaline decreases expression EXP 6480464 Monocrotaline results in decreased expression of CTNNB1 protein CTD PMID:21619414 myricetin decreases expression ISO RGD:733705 6480464 myricetin results in decreased expression of CTNNB1 protein CTD PMID:22245592 myricetin multiple interactions ISO RGD:733705 6480464 [myricetin results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein CTD PMID:22245592 N(6),N(6)-dimethyladenine multiple interactions EXP 6480464 N(6), N(6)-dimethyladenine promotes the reaction [Cadmium Chloride results in decreased expression of CTNNB1 protein] CTD PMID:15618353 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:733705 6480464 [IFNG protein co-treated with TNF protein co-treated with N more ... CTD PMID:16844947 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:733705 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Lithium Chloride affects the localization of CTNNB1 protein modified form], N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Lithium Chloride affects the localization of CTNNB1 protein] CTD PMID:22493441 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Epinephrine results in increased phosphorylation of CTNNB1 protein], N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [GCG protein results in increased phosphorylation of CTNNB1 protein] CTD PMID:26964897 N-acetyl-L-cysteine multiple interactions ISO RGD:1550466 6480464 Acetylcysteine inhibits the reaction [TALDO1 gene mutant form results in decreased phosphorylation of CTNNB1 protein] CTD PMID:19436114 N-acetyl-L-cysteine multiple interactions ISO RGD:733705 6480464 Acetylcysteine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CTNNB1 protein] more ... CTD PMID:16282376 more ... N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Aspirin results in increased ubiquitination of CTNNB1 protein] more ... CTD PMID:14555707 more ... N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases degradation ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of CTNNB1 protein CTD PMID:26990689 , PMID:32112862 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1550466 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde affects the phosphorylation of and affects the localization of CTNNB1 protein more ... CTD PMID:27693619 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions EXP 6480464 geraniol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CTNNB1 mRNA] CTD PMID:28428697 N-methyl-N'-nitro-N-nitrosoguanidine increases expression EXP 6480464 Methylnitronitrosoguanidine results in increased expression of CTNNB1 mRNA CTD PMID:28428697 N-methyl-N-nitrosourea increases expression ISO RGD:1550466 6480464 Methylnitrosourea results in increased expression of CTNNB1 protein CTD PMID:12096346 N-nitrosodiethylamine multiple interactions ISO RGD:1550466 6480464 [Diethylnitrosamine co-treated with Dietary Fats] results in increased expression of and results in increased phosphorylation of CTNNB1 protein more ... CTD PMID:20583210 more ... N-nitrosodiethylamine increases expression ISO RGD:1550466 6480464 Diethylnitrosamine results in increased expression of CTNNB1 mRNA, Diethylnitrosamine results in increased expression of CTNNB1 protein CTD PMID:20583210 , PMID:27058323 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CTNNB1 mRNA CTD PMID:21554863 N-nitrosodiethylamine affects localization EXP 6480464 Diethylnitrosamine affects the localization of CTNNB1 protein modified form CTD PMID:21554863 N-nitrosodiethylamine multiple interactions EXP 6480464 5 more ... CTD PMID:21554863 N-nitrosodiethylamine increases mutagenesis EXP 6480464 Diethylnitrosamine results in increased mutagenesis of CTNNB1 CTD PMID:10463579 N-nitrosodiethylamine decreases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased susceptibility to Diethylnitrosamine CTD PMID:20583210 N-tosyl-L-phenylalanyl chloromethyl ketone multiple interactions ISO RGD:733705 6480464 Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Nitroglycerin inhibits the reaction [CTNNB1 protein binds to TCF4 protein]] more ... CTD PMID:17030184 naproxen multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein], Naproxen inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein] CTD PMID:22150557 naringin increases expression ISO RGD:733705 6480464 naringin results in increased expression of CTNNB1 mRNA CTD PMID:24915843 naringin multiple interactions ISO RGD:733705 6480464 naringin inhibits the reaction [Hydrogen Peroxide results in decreased expression of CTNNB1 protein] CTD PMID:26482937 Niclosamide increases expression ISO RGD:733705 6480464 Niclosamide results in increased expression of CTNNB1 mRNA CTD PMID:22576131 Niclosamide increases ubiquitination ISO RGD:733705 6480464 Niclosamide results in increased ubiquitination of CTNNB1 protein CTD PMID:27492973 Niclosamide multiple interactions ISO RGD:733705 6480464 Imatinib Mesylate promotes the reaction [Niclosamide results in decreased expression of CTNNB1 protein] more ... CTD PMID:19772353 more ... Niclosamide decreases expression ISO RGD:733705 6480464 Niclosamide analog results in decreased expression of CTNNB1 protein, Niclosamide results in decreased expression of CTNNB1 protein CTD PMID:21531761 more ... Niclosamide multiple interactions EXP 6480464 Niclosamide inhibits the reaction [Epinephrine results in increased phosphorylation of CTNNB1 protein], Niclosamide inhibits the reaction [GCG protein results in increased phosphorylation of CTNNB1 protein] CTD PMID:26964897 Niclosamide decreases expression ISO RGD:1550466 6480464 Niclosamide results in decreased expression of CTNNB1 mRNA CTD PMID:27226553 Niclosamide decreases activity ISO RGD:733705 6480464 Niclosamide results in decreased activity of CTNNB1 protein CTD PMID:25174399 nimesulide affects localization ISO RGD:733705 6480464 nimesulide affects the localization of CTNNB1 protein CTD PMID:16331303 nimesulide decreases expression ISO RGD:1550466 6480464 nimesulide results in decreased expression of CTNNB1 CTD PMID:15892897 nitroglycerin multiple interactions ISO RGD:733705 6480464 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Nitroglycerin results in decreased localization of CTNNB1 protein] more ... CTD PMID:17030184 nitroglycerin decreases localization ISO RGD:733705 6480464 Nitroglycerin results in decreased localization of CTNNB1 protein CTD PMID:17030184 O-methyleugenol increases mutagenesis ISO RGD:1550466 6480464 methyleugenol results in increased mutagenesis of CTNNB1 gene CTD PMID:10467420 ochratoxin A increases expression ISO RGD:733705 6480464 ochratoxin A metabolite results in increased expression of CTNNB1 mRNA, ochratoxin A results in increased expression of CTNNB1 mRNA CTD PMID:26314263 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of CTNNB1 protein CTD PMID:31369848 okadaic acid increases phosphorylation ISO RGD:733705 6480464 Okadaic Acid results in increased phosphorylation of CTNNB1 protein CTD PMID:16878161 okadaic acid increases expression ISO RGD:733705 6480464 Okadaic Acid results in increased expression of CTNNB1 mRNA CTD PMID:31115591 okadaic acid multiple interactions ISO RGD:733705 6480464 Okadaic Acid promotes the reaction [CTNNB1 protein binds to CDH1 protein] more ... CTD PMID:31115591 olanzapine decreases expression ISO RGD:1550466 6480464 olanzapine results in decreased expression of CTNNB1 mRNA CTD PMID:18797397 olanzapine increases expression ISO RGD:733705 6480464 Olanzapine results in increased expression of CTNNB1 mRNA CTD PMID:31563592 olanzapine multiple interactions ISO RGD:733705 6480464 Olanzapine inhibits the reaction [Dizocilpine Maleate results in decreased expression of CTNNB1 mRNA] CTD PMID:31563592 oxazepam increases mutagenesis ISO RGD:1550466 6480464 Oxazepam results in increased mutagenesis of CTNNB1 gene CTD PMID:10467420 p-menthan-3-ol decreases expression ISO RGD:733705 6480464 Menthol results in decreased expression of CTNNB1 mRNA CTD PMID:26760959 paclitaxel decreases phosphorylation ISO RGD:733705 6480464 Paclitaxel results in decreased phosphorylation of CTNNB1 protein CTD PMID:23956100 paclitaxel decreases response to substance ISO RGD:733705 6480464 CTNNB1 results in decreased susceptibility to Paclitaxel CTD PMID:22000491 palbociclib multiple interactions ISO RGD:733705 6480464 2-(5-benzo(1, 3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride inhibits the reaction [palbociclib results in increased expression of CTNNB1 protein] CTD PMID:22869556 palbociclib increases expression ISO RGD:733705 6480464 palbociclib results in increased expression of CTNNB1 protein CTD PMID:22869556 paracetamol affects expression ISO RGD:1550466 6480464 Acetaminophen affects the expression of CTNNB1 mRNA CTD PMID:17562736 , PMID:19679878 paracetamol multiple interactions ISO RGD:733705 6480464 Acetaminophen promotes the reaction [CTNNB1 protein binds to PPP2R5A protein] more ... CTD PMID:30567741 paracetamol affects localization ISO RGD:733705 6480464 Acetaminophen affects the localization of CTNNB1 protein CTD PMID:30567741 paracetamol decreases expression ISO RGD:733705 6480464 Acetaminophen results in decreased expression of CTNNB1 mRNA CTD PMID:27761495 paracetamol increases expression ISO RGD:733705 6480464 Acetaminophen results in increased expression of CTNNB1 mRNA CTD PMID:21420995 paracetamol increases response to substance ISO RGD:1550466 6480464 CTNNB1 mutant form results in increased susceptibility to Acetaminophen CTD PMID:19679878 paracetamol multiple interactions ISO RGD:1550466 6480464 Acetaminophen results in increased expression of and results in increased activity of CTNNB1 protein CTD PMID:19679878 paracetamol affects localization ISO RGD:1550466 6480464 Acetaminophen affects the localization of CTNNB1 protein CTD PMID:19679878 paraquat multiple interactions ISO RGD:1550466 6480464 CTNNB1 protein inhibits the reaction [Paraquat results in increased abundance of Reactive Oxygen Species] more ... CTD PMID:23620592 more ... paraquat multiple interactions ISO RGD:733705 6480464 LGK974 inhibits the reaction [Paraquat affects the localization of CTNNB1 protein] more ... CTD PMID:30171970 , PMID:30205152 paraquat decreases expression ISO RGD:1550466 6480464 Paraquat results in decreased expression of CTNNB1 mRNA, Paraquat results in decreased expression of CTNNB1 protein CTD PMID:27788593 , PMID:30171970 paraquat affects localization ISO RGD:733705 6480464 Paraquat affects the localization of CTNNB1 protein CTD PMID:30205152 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CTNNB1 mRNA CTD PMID:26887261 paraquat decreases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased susceptibility to Paraquat CTD PMID:23620592 parathion multiple interactions ISO RGD:733705 6480464 Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein mutant form], Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein] CTD PMID:17390078 parathion increases expression ISO RGD:733705 6480464 Parathion results in increased expression of CTNNB1 protein CTD PMID:17390078 perfluorooctane-1-sulfonic acid affects expression ISO RGD:733705 6480464 perfluorooctane sulfonic acid affects the expression of CTNNB1 mRNA CTD PMID:30738844 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1550466 6480464 perfluorooctane sulfonic acid results in decreased expression of CTNNB1 protein CTD PMID:27018151 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1550466 6480464 Lithium Chloride inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of CTNNB1 protein] CTD PMID:27018151 perfluorooctanoic acid decreases expression ISO RGD:733705 6480464 perfluorooctanoic acid results in decreased expression of CTNNB1 protein CTD PMID:23978332 perfluorooctanoic acid decreases expression ISO RGD:1550466 6480464 perfluorooctanoic acid results in decreased expression of CTNNB1 protein CTD PMID:25743374 perfluorooctanoic acid multiple interactions ISO RGD:733705 6480464 [MK-886 binds to and results in decreased activity of PPARA protein] inhibits the reaction [perfluorooctanoic acid results in decreased expression of CTNNB1 protein] CTD PMID:23978332 pevonedistat increases abundance ISO RGD:1550466 6480464 pevonedistat results in increased abundance of CTNNB1 protein CTD PMID:22110742 phenethyl caffeate decreases expression ISO RGD:1550466 6480464 caffeic acid phenethyl ester results in decreased expression of CTNNB1 protein CTD PMID:10783313 phenobarbital affects response to substance ISO RGD:1550466 6480464 CTNNB1 protein affects the susceptibility to Phenobarbital CTD PMID:21705713 phenobarbital increases expression ISO RGD:1550466 6480464 Phenobarbital results in increased expression of CTNNB1 protein alternative form CTD PMID:31836555 phenobarbital increases mutagenesis ISO RGD:1550466 6480464 Phenobarbital results in increased mutagenesis of CTNNB1 exon more ... CTD PMID:11753661 more ... phenobarbital multiple interactions ISO RGD:1550466 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased mutagenesis of CTNNB1 gene more ... CTD PMID:12384525 more ... phenol red multiple interactions ISO RGD:733705 6480464 [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of CTNNB1 protein CTD PMID:31629898 phenylephrine multiple interactions EXP 6480464 Phenylephrine promotes the reaction [CTNNB1 protein binds to NPPA promoter] CTD PMID:19799869 phenylmercury acetate increases expression ISO RGD:733705 6480464 Phenylmercuric Acetate results in increased expression of CTNNB1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733705 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTNNB1 mRNA CTD PMID:27188386 PhIP multiple interactions EXP 6480464 [2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:11756241 more ... PhIP multiple interactions ISO RGD:1550466 6480464 [2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:15459021 , PMID:27664423 PhIP increases mutagenesis EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased mutagenesis of CTNNB1 gene CTD PMID:10965019 more ... PhIP increases expression ISO RGD:1550466 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of CTNNB1 protein CTD PMID:21081470 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:14507667 , PMID:23466459 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:733705 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [CDH5 protein binds to CTNNB1 protein] CTD PMID:24211779 pinosylvin multiple interactions ISO RGD:733705 6480464 [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA more ... CTD PMID:23333577 pioglitazone multiple interactions ISO RGD:733705 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA CTD PMID:20847119 piperine multiple interactions ISO RGD:733705 6480464 [piperine co-treated with Curcumin] results in decreased expression of CTNNB1 protein CTD PMID:30935902 pirinixic acid multiple interactions EXP 6480464 pirinixic acid inhibits the reaction [APP protein results in decreased expression of CTNNB1 protein] more ... CTD PMID:16204253 pirinixic acid decreases expression ISO RGD:1550466 6480464 pirinixic acid results in decreased expression of CTNNB1 mRNA CTD PMID:18445702 platycodin D multiple interactions ISO RGD:1550466 6480464 CTNNB1 affects the reaction [platycodin D results in decreased expression of CEBPA protein] more ... CTD PMID:21798269 pravastatin affects localization EXP 6480464 Pravastatin affects the localization of CTNNB1 protein CTD PMID:17188708 pravastatin multiple interactions EXP 6480464 [resveratrol co-treated with Pravastatin] affects the localization of CTNNB1 protein CTD PMID:17188708 Pristimerin decreases expression ISO RGD:733705 6480464 pristimerin results in decreased expression of CTNNB1 protein CTD PMID:31715269 Pristimerin multiple interactions ISO RGD:733705 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [pristimerin results in decreased expression of CTNNB1 protein] more ... CTD PMID:31715269 Pristimerin multiple interactions ISO RGD:1550466 6480464 pristimerin affects the reaction [APC protein mutant form affects the expression of CTNNB1 protein], pristimerin inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CTNNB1 protein] CTD PMID:31715269 progesterone increases expression EXP 6480464 Progesterone results in increased expression of CTNNB1 protein CTD PMID:17170212 progesterone decreases abundance ISO RGD:1550466 6480464 CTNNB1 protein results in decreased abundance of Progesterone CTD PMID:20610534 progesterone increases response to substance ISO RGD:1550466 6480464 CTNNB1 protein results in increased susceptibility to Progesterone CTD PMID:22958837 prostaglandin E2 increases localization ISO RGD:733705 6480464 Dinoprostone results in increased localization of CTNNB1 protein CTD PMID:18395713 prostaglandin E2 increases expression ISO RGD:733705 6480464 Dinoprostone results in increased expression of CTNNB1 protein CTD PMID:30208247 prostaglandin E2 multiple interactions ISO RGD:733705 6480464 cryptotanshinone inhibits the reaction [Dinoprostone results in increased expression of CTNNB1 protein] CTD PMID:30208247 puromycin affects localization ISO RGD:1550466 6480464 Puromycin affects the localization of CTNNB1 protein CTD PMID:15673299 pyocyanine increases expression ISO RGD:1550466 6480464 Pyocyanine results in increased expression of CTNNB1 mRNA CTD PMID:31078726 pyrithione multiple interactions EXP 6480464 [Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein CTD PMID:17098228 quercetin decreases expression ISO RGD:733705 6480464 Quercetin results in decreased expression of CTNNB1 mRNA, Quercetin results in decreased expression of CTNNB1 protein CTD PMID:20596804 more ... quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of CTNNB1 mRNA, Quercetin results in decreased expression of CTNNB1 protein CTD PMID:20501703 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Warfarin results in increased expression of and affects the localization of CTNNB1 protein] more ... CTD PMID:20501703 , PMID:23117658 quercetin multiple interactions ISO RGD:733705 6480464 [Quercetin results in increased activity of SIRT1 protein] which results in decreased expression of CTNNB1 protein more ... CTD PMID:15670774 more ... quercetin decreases activity ISO RGD:733705 6480464 Quercetin results in decreased activity of CTNNB1 protein CTD PMID:15670774 , PMID:19440933 quercetin affects expression ISO RGD:733705 6480464 Quercetin affects the expression of CTNNB1 protein CTD PMID:15670774 quercetin 3-O-beta-D-glucofuranoside affects expression ISO RGD:733705 6480464 isoquercitrin affects the expression of CTNNB1 mRNA CTD PMID:30597948 quercetin 3-O-beta-D-glucopyranoside affects expression ISO RGD:733705 6480464 isoquercitrin affects the expression of CTNNB1 mRNA CTD PMID:30597948 quinacrine multiple interactions ISO RGD:733705 6480464 GSK3B protein affects the reaction [Quinacrine results in decreased expression of CTNNB1 protein] CTD PMID:28720477 quinacrine decreases expression ISO RGD:733705 6480464 Quinacrine results in decreased expression of CTNNB1 protein CTD PMID:28720477 rac-lactic acid increases expression ISO RGD:733705 6480464 Lactic Acid results in increased expression of CTNNB1 mRNA CTD PMID:30851411 reactive oxygen species multiple interactions ISO RGD:1550466 6480464 CTNNB1 protein inhibits the reaction [Paraquat results in increased abundance of Reactive Oxygen Species] CTD PMID:23620592 resveratrol affects localization EXP 6480464 resveratrol affects the localization of CTNNB1 protein CTD PMID:17188708 resveratrol affects localization ISO RGD:733705 6480464 resveratrol affects the localization of CTNNB1 protein CTD PMID:22314268 more ... resveratrol increases degradation ISO RGD:733705 6480464 resveratrol results in increased degradation of CTNNB1 protein CTD PMID:26040106 resveratrol decreases expression ISO RGD:733705 6480464 resveratrol results in decreased expression of CTNNB1 mRNA, resveratrol results in decreased expression of CTNNB1 protein CTD PMID:11895924 more ... resveratrol affects localization ISO RGD:1550466 6480464 resveratrol affects the localization of CTNNB1 protein CTD PMID:19665018 resveratrol multiple interactions ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased stability of CTNNB1 protein] more ... CTD PMID:20542495 more ... resveratrol increases activity ISO RGD:1550466 6480464 resveratrol results in increased activity of CTNNB1 protein CTD PMID:19665018 resveratrol increases stability ISO RGD:1550466 6480464 resveratrol results in increased stability of CTNNB1 protein CTD PMID:19665018 , PMID:20542495 resveratrol multiple interactions ISO RGD:733705 6480464 [[Resveratrol results in increased activity of SIRT1 protein] promotes the reaction [SIRT1 protein binds to and results in decreased activity of EP300 protein]] which results in decreased acetylation of and results in decreased activity of CTNNB1 protein more ... CTD PMID:19047049 more ... resveratrol increases expression EXP 6480464 resveratrol results in increased expression of CTNNB1 mRNA CTD PMID:23848300 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Pravastatin] affects the localization of CTNNB1 protein CTD PMID:17188708 riboflavin increases expression ISO RGD:1550466 6480464 Riboflavin analog results in increased expression of CTNNB1 protein CTD PMID:20688149 risperidone multiple interactions EXP 6480464 DRD2 protein affects the reaction [Risperidone results in increased expression of CTNNB1 protein] CTD PMID:16144542 risperidone increases expression EXP 6480464 Risperidone results in increased expression of CTNNB1 protein CTD PMID:16144542 rotenone multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [Rotenone results in decreased expression of and results in decreased phosphorylation of CTNNB1 protein], Rotenone results in decreased expression of and results in decreased phosphorylation of CTNNB1 protein CTD PMID:27045591 Salinomycin multiple interactions ISO RGD:733705 6480464 salinomycin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased activity of CTNNB1 mRNA] CTD PMID:26896736 SB 203580 multiple interactions ISO RGD:733705 6480464 SB 203580 inhibits the reaction [DEFA1 protein results in decreased phosphorylation of and results in increased activity of CTNNB1 protein], SB 203580 inhibits the reaction [DEFA2 protein results in decreased phosphorylation of and results in increased activity of CTNNB1 protein] CTD PMID:19814765 SB 415286 multiple interactions ISO RGD:1550466 6480464 [3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2, 5-dione results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein CTD PMID:19159680 SB 431542 multiple interactions ISO RGD:733705 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos decreases expression ISO RGD:733705 6480464 Asbestos, Serpentine results in decreased expression of CTNNB1 mRNA, Asbestos, Serpentine results in decreased expression of CTNNB1 protein CTD PMID:26685284 serpentine asbestos multiple interactions ISO RGD:733705 6480464 Asbestos, Serpentine results in increased phosphorylation of and affects the localization of CTNNB1 protein more ... CTD PMID:24160326 , PMID:26685284 silicon dioxide increases expression ISO RGD:1550466 6480464 Silicon Dioxide results in increased expression of CTNNB1 mRNA CTD PMID:29203145 simvastatin multiple interactions ISO RGD:1550466 6480464 CTNNB1 mutant form inhibits the reaction [Simvastatin results in increased expression of BGLAP protein], CTNNB1 mutant form inhibits the reaction [Simvastatin results in increased expression of SP7 protein] CTD PMID:22058016 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of CTNNB1 protein CTD PMID:18004065 simvastatin increases expression ISO RGD:1550466 6480464 Simvastatin results in increased expression of CTNNB1 protein CTD PMID:22058016 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein] CTD PMID:18004065 sirolimus multiple interactions EXP 6480464 Sirolimus promotes the reaction [Dibutyl Phthalate results in increased expression of CTNNB1 mRNA] CTD PMID:30053495 sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of CTNNB1 mRNA, sodium arsenate results in decreased expression of CTNNB1 protein CTD PMID:14713550 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CTNNB1 mRNA CTD PMID:23137061 sodium arsenite affects localization ISO RGD:733705 6480464 sodium arsenite affects the localization of CTNNB1 protein CTD PMID:22859221 sodium arsenite increases expression ISO RGD:1550466 6480464 sodium arsenite results in increased expression of CTNNB1 mRNA CTD PMID:25825268 sodium arsenite decreases expression ISO RGD:1550466 6480464 sodium arsenite results in decreased expression of CTNNB1 mRNA, sodium arsenite results in decreased expression of CTNNB1 protein CTD PMID:23143138 , PMID:27158593 sodium arsenite affects expression ISO RGD:1550466 6480464 sodium arsenite affects the expression of CTNNB1 mRNA CTD PMID:16507464 , PMID:28206643 sodium arsenite multiple interactions ISO RGD:1550466 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [sodium arsenite results in decreased expression of CTNNB1 protein], [Folic Acid co-treated with sodium arsenite] results in increased methylation of CTNNB1 mRNA CTD PMID:22959928 , PMID:23143138 sodium arsenite increases expression ISO RGD:733705 6480464 sodium arsenite results in increased expression of CTNNB1 protein CTD PMID:16054901 more ... sodium arsenite decreases expression ISO RGD:733705 6480464 sodium arsenite results in decreased expression of CTNNB1 protein CTD PMID:23219847 , PMID:25879800 sodium arsenite multiple interactions ISO RGD:733705 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite affects the localization of CTNNB1 protein] more ... CTD PMID:22859221 more ... sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of CTNNB1 mRNA CTD PMID:24300170 sodium fluoride increases expression ISO RGD:1550466 6480464 Sodium Fluoride results in increased expression of CTNNB1 mRNA, Sodium Fluoride results in increased expression of CTNNB1 protein CTD PMID:29447955 sodium fluoride multiple interactions ISO RGD:1550466 6480464 [Sodium Fluoride results in increased susceptibility to PTH protein] which results in increased expression of CTNNB1 mRNA, PTH protein promotes the reaction [Sodium Fluoride results in increased expression of CTNNB1 mRNA] CTD PMID:29447955 sodium fluoride decreases expression ISO RGD:1550466 6480464 Sodium Fluoride results in decreased expression of CTNNB1 protein CTD PMID:28918527 sodium fluoride multiple interactions EXP 6480464 Sodium Fluoride results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:24300170 sorafenib multiple interactions ISO RGD:733705 6480464 sorafenib promotes the reaction [destruxin B results in decreased expression of CTNNB1 protein] CTD PMID:24434019 Sporidesmin affects localization ISO RGD:733705 6480464 sporidesmin affects the localization of CTNNB1 protein CTD PMID:28193462 staurosporine increases phosphorylation EXP 6480464 Staurosporine results in increased phosphorylation of CTNNB1 protein CTD PMID:19741129 SU6656 affects localization ISO RGD:733705 6480464 SU 6656 affects the localization of CTNNB1 protein CTD PMID:23527294 sulfasalazine multiple interactions ISO RGD:1550466 6480464 [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in decreased localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of CCND1 mRNA, [Sulfasalazine results in decreased activity of SLC7A11 protein] which results in decreased localization of and results in decreased activity of CTNNB1 protein CTD PMID:19015640 sulfasalazine multiple interactions EXP 6480464 Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 mRNA], Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CTNNB1 protein] CTD PMID:26165751 sulindac multiple interactions ISO RGD:733705 6480464 CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CCND1 protein] more ... CTD PMID:11751639 , PMID:18291362 sulindac multiple interactions EXP 6480464 epigallocatechin gallate promotes the reaction [Sulindac inhibits the reaction [1 more ... CTD PMID:29999212 sulindac decreases expression ISO RGD:1550466 6480464 Sulindac results in decreased expression of CTNNB1 protein CTD PMID:10223192 sulindac multiple interactions ISO RGD:1550466 6480464 [Sulindac co-treated with Plant Extracts] results in decreased expression of CTNNB1 protein CTD PMID:12351151 sulindac decreases expression ISO RGD:733705 6480464 Sulindac results in decreased expression of CTNNB1 protein CTD PMID:18291362 sulindac sulfide multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfide results in decreased expression of CTNNB1 protein] more ... CTD PMID:14555707 more ... sulindac sulfide decreases expression ISO RGD:733705 6480464 sulindac sulfide results in decreased expression of CTNNB1 protein CTD PMID:14555707 sulindac sulfone increases expression ISO RGD:733705 6480464 sulindac sulfone results in increased expression of CTNNB1 protein CTD PMID:11602670 sulindac sulfone decreases expression ISO RGD:733705 6480464 sulindac sulfone results in decreased expression of CTNNB1 protein CTD PMID:10910034 more ... sulindac sulfone multiple interactions ISO RGD:733705 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfone results in decreased expression of CTNNB1 protein] CTD PMID:14555707 sumatriptan multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein], Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CTNNB1 protein] CTD PMID:22150557 sunitinib increases expression ISO RGD:733705 6480464 sunitinib results in increased expression of CTNNB1 mRNA CTD PMID:25605917 tamoxifen multiple interactions ISO RGD:733705 6480464 3 more ... CTD PMID:22046442 , PMID:23921149 tamoxifen decreases expression ISO RGD:733705 6480464 Tamoxifen results in decreased expression of CTNNB1 protein CTD PMID:23921149 Tanshinone I increases expression ISO RGD:1550466 6480464 tanshinone results in increased expression of CTNNB1 mRNA CTD PMID:25186638 tert-butyl hydroperoxide multiple interactions ISO RGD:733705 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA more ... CTD PMID:20847119 tert-butyl hydroperoxide increases expression ISO RGD:733705 6480464 tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA CTD PMID:20847119 testosterone increases expression ISO RGD:733705 6480464 Testosterone results in increased expression of CTNNB1 protein CTD PMID:21468052 testosterone multiple interactions ISO RGD:733705 6480464 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3 more ... CTD PMID:28163245 testosterone decreases phosphorylation ISO RGD:733705 6480464 Testosterone results in decreased phosphorylation of CTNNB1 protein CTD PMID:28163245 testosterone increases expression ISO RGD:1550466 6480464 Testosterone results in increased expression of CTNNB1 protein CTD PMID:21468052 tetrachloromethane multiple interactions ISO RGD:1550466 6480464 NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 protein]], tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 protein] CTD PMID:27477297 tetrachloromethane increases expression ISO RGD:1550466 6480464 Carbon Tetrachloride results in increased expression of CTNNB1 protein CTD PMID:27477297 , PMID:29535048 tetramethylpyrazine decreases expression ISO RGD:733705 6480464 tetramethylpyrazine results in decreased expression of CTNNB1 mRNA, tetramethylpyrazine results in decreased expression of CTNNB1 protein CTD PMID:27477297 tetramethylpyrazine multiple interactions ISO RGD:733705 6480464 NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of CTNNB1 mRNA] more ... CTD PMID:24961358 , PMID:27477297 tetramethylpyrazine multiple interactions ISO RGD:1550466 6480464 NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 protein]], tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of CTNNB1 protein] CTD PMID:27477297 theaflavin multiple interactions ISO RGD:1550466 6480464 theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 mRNA], theaflavin inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 protein] CTD PMID:27058323 titanium dioxide affects expression ISO RGD:1550466 6480464 titanium dioxide affects the expression of CTNNB1 mRNA CTD PMID:17656681 toluene 2,4-diisocyanate increases phosphorylation ISO RGD:1550466 6480464 Toluene 2, 4-Diisocyanate results in increased phosphorylation of CTNNB1 protein CTD PMID:26089345 toluene 2,4-diisocyanate affects localization ISO RGD:733705 6480464 Toluene 2, 4-Diisocyanate analog affects the localization of CTNNB1 protein CTD PMID:30261222 toluene 2,4-diisocyanate affects localization ISO RGD:1550466 6480464 Toluene 2, 4-Diisocyanate affects the localization of CTNNB1 protein CTD PMID:30261222 toluene 2,4-diisocyanate multiple interactions ISO RGD:733705 6480464 AG 1879 inhibits the reaction [Toluene 2 more ... CTD PMID:30261222 toluene 2,4-diisocyanate multiple interactions ISO RGD:1550466 6480464 2-(1 more ... CTD PMID:26089345 more ... topotecan multiple interactions ISO RGD:733705 6480464 acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Topotecan results in increased cleavage of CTNNB1 protein], chrysin inhibits the reaction [Topotecan results in increased cleavage of CTNNB1 protein] CTD PMID:20457140 topotecan increases cleavage ISO RGD:733705 6480464 Topotecan results in increased cleavage of CTNNB1 protein CTD PMID:20457140 trans-pinosylvin multiple interactions ISO RGD:733705 6480464 [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA more ... CTD PMID:23333577 tremolite asbestos multiple interactions ISO RGD:733705 6480464 tremolite results in decreased expression of and affects the localization of CTNNB1 protein CTD PMID:22578742 tributylstannane increases expression ISO RGD:733705 6480464 tributyltin results in increased expression of CTNNB1 mRNA CTD PMID:26314263 Tributyltin oxide increases expression ISO RGD:733705 6480464 bis(tri-n-butyltin)oxide results in increased expression of CTNNB1 mRNA CTD PMID:26314263 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CTNNB1 mRNA CTD PMID:14565619 trichostatin A multiple interactions ISO RGD:733705 6480464 [3-deazaneplanocin co-treated with trichostatin A] affects the expression of CTNNB1 protein more ... CTD PMID:18538736 more ... trichostatin A increases expression ISO RGD:733705 6480464 trichostatin A results in increased expression of CTNNB1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1550466 6480464 [estradiol dipropionate co-treated with trichostatin A] results in decreased expression of CTNNB1 protein CTD PMID:15930180 troglitazone multiple interactions ISO RGD:733705 6480464 [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA, troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA] CTD PMID:20847119 troglitazone decreases expression ISO RGD:1550466 6480464 troglitazone results in decreased expression of CTNNB1 CTD PMID:15892897 tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate multiple interactions ISO RGD:733705 6480464 Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein mutant form], Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein] CTD PMID:17390078 tyrphostin AG 1478 multiple interactions ISO RGD:733705 6480464 RTKI cpd inhibits the reaction [arsenite affects the localization of CTNNB1 protein] CTD PMID:17400267 tyrphostin AG 1478 decreases expression ISO RGD:733705 6480464 RTKI cpd results in decreased expression of CTNNB1 protein CTD PMID:29974605 uranium atom decreases expression EXP 6480464 Uranium analog results in decreased expression of CTNNB1 mRNA CTD PMID:27544493 ursolic acid multiple interactions ISO RGD:733705 6480464 ursolic acid results in increased phosphorylation of and results in increased degradation of CTNNB1 protein CTD PMID:24566423 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CTNNB1 protein CTD PMID:12942141 , PMID:20734317 valproic acid multiple interactions ISO RGD:733705 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTNNB1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:733705 6480464 Valproic Acid results in increased expression of CTNNB1 mRNA CTD PMID:24383497 more ... valproic acid affects expression ISO RGD:733705 6480464 Valproic Acid affects the expression of CTNNB1 mRNA CTD PMID:23179753 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of CTNNB1 protein CTD PMID:18511088 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CTNNB1 mRNA CTD PMID:19015723 vincristine increases expression ISO RGD:733705 6480464 Vincristine results in increased expression of CTNNB1 mRNA CTD PMID:23649840 vincristine decreases response to substance ISO RGD:733705 6480464 CTNNB1 results in decreased susceptibility to Vincristine CTD PMID:22000491 vinyl carbamate increases mutagenesis ISO RGD:1550466 6480464 vinyl carbamate results in increased mutagenesis of CTNNB1 gene CTD PMID:10467420 vitamin E multiple interactions ISO RGD:733705 6480464 Vitamin E inhibits the reaction [Curcumin results in decreased expression of CTNNB1 protein] CTD PMID:30935902 vitamin E multiple interactions EXP 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and affects the localization of CTNNB1 protein], [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein] CTD PMID:29940330 vorinostat multiple interactions ISO RGD:733705 6480464 vorinostat results in increased expression of and results in increased activity of CTNNB1 protein CTD PMID:17417771 warfarin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Warfarin results in increased expression of and affects the localization of CTNNB1 protein], Warfarin results in increased expression of and affects the localization of CTNNB1 protein CTD PMID:23117658 warfarin affects response to substance EXP 6480464 CTNNB1 protein affects the susceptibility to Warfarin CTD PMID:23223575 warfarin multiple interactions ISO RGD:733705 6480464 Warfarin results in decreased expression of and affects the localization of CTNNB1 protein CTD PMID:26206560 wogonin multiple interactions ISO RGD:733705 6480464 Lithium Chloride inhibits the reaction [wogonin results in decreased expression of CTNNB1 protein] CTD PMID:23872260 wogonin multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [wogonin results in decreased expression of CTNNB1 protein], wogonin inhibits the reaction [Cisplatin results in increased expression of CTNNB1 protein] CTD PMID:23872260 , PMID:31103702 wogonin increases expression ISO RGD:733705 6480464 wogonin results in increased expression of CTNNB1 protein modified form CTD PMID:23872260 wogonin decreases expression ISO RGD:733705 6480464 wogonin results in decreased expression of CTNNB1 protein CTD PMID:23872260 wogonin decreases expression EXP 6480464 wogonin results in decreased expression of CTNNB1 protein CTD PMID:23872260 wogonin increases expression EXP 6480464 wogonin results in increased expression of CTNNB1 protein modified form CTD PMID:23872260 wortmannin decreases expression ISO RGD:733705 6480464 wortmannin results in decreased expression of CTNNB1 protein CTD PMID:11739494 wortmannin multiple interactions ISO RGD:733705 6480464 wortmannin inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CTNNB1 protein] more ... CTD PMID:28163245 , PMID:28321046 wortmannin increases phosphorylation ISO RGD:733705 6480464 wortmannin results in increased phosphorylation of CTNNB1 protein CTD PMID:28163245 xanthohumol multiple interactions EXP 6480464 xanthohumol inhibits the reaction [Azoxymethane results in decreased phosphorylation of and results in increased activity of CTNNB1 protein] CTD PMID:31714664 XAV939 multiple interactions ISO RGD:733705 6480464 XAV939 inhibits the reaction [CTNNB1 protein binds to CTNNBIP1 protein] more ... CTD PMID:24534281 , PMID:32112862 XAV939 decreases expression ISO RGD:1550466 6480464 XAV939 results in decreased expression of CTNNB1 mRNA CTD PMID:27226553 XAV939 decreases expression EXP 6480464 XAV939 results in decreased expression of CTNNB1 protein CTD PMID:24231000 XAV939 multiple interactions EXP 6480464 XAV939 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CTNNB1 protein] CTD PMID:24231000 XAV939 decreases expression ISO RGD:733705 6480464 XAV939 results in decreased expression of CTNNB1 protein CTD PMID:25061499 zinc atom multiple interactions ISO RGD:733705 6480464 Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N more ... CTD PMID:16844947 zinc atom multiple interactions EXP 6480464 [Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein, Zinc deficiency results in decreased activity of and results in decreased expression of CTNNB1 protein CTD PMID:17098228 , PMID:21893222 zinc(0) multiple interactions ISO RGD:733705 6480464 Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N more ... CTD PMID:16844947 zinc(0) multiple interactions EXP 6480464 [Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein, Zinc deficiency results in decreased activity of and results in decreased expression of CTNNB1 protein CTD PMID:17098228 , PMID:21893222
Biological Process adherens junction assembly ISO RGD:733705 1624291 (PMID:20086044), (PMID:20123964) RGD PMID:20086044 , PMID:20123964 adherens junction assembly IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 adherens junction assembly ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 adherens junction organization ISO RGD:1550466 1624291 (MGI:MGI:3829282, PMID:19129494) RGD MGI:MGI:3829282 , PMID:19129494 animal organ development ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:3807613 , PMID:18635608) RGD MGI:MGI:3807613 , PMID:18635608 anterior/posterior axis specification ISO RGD:1550466 1624291 MGI:MGI:2148590 (MGI:MGI:1353237 , PMID:10662781) RGD MGI:MGI:1353237 , PMID:10662781 anterior/posterior axis specification IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 astrocyte-dopaminergic neuron signaling IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 astrocyte-dopaminergic neuron signaling ISO RGD:1550466 1624291 (MGI:MGI:5770063, PMID:21752258) RGD MGI:MGI:5770063 , PMID:21752258 bicellular tight junction assembly ISO RGD:12299678 1624291 (PMID:8636221) RGD PMID:8636221 bone remodeling IEP 13792728 RGD bone resorption ISO RGD:1550466 1624291 MGI:MGI:1858008 more ... RGD MGI:MGI:3578468 , PMID:15866165 bone resorption IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 branching involved in blood vessel morphogenesis ISO RGD:1550466 1624291 MGI:MGI:1858008 more ... RGD MGI:MGI:2675534 more ... branching involved in blood vessel morphogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 branching involved in ureteric bud morphogenesis ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:3714576 , PMID:17537789) RGD MGI:MGI:3714576 , PMID:17537789 branching involved in ureteric bud morphogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 canonical Wnt signaling pathway ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 canonical Wnt signaling pathway ISO RGD:1550466 1624291 MGI:MGI:109330 more ... RGD MGI:MGI:2386811 more ... canonical Wnt signaling pathway ISO RGD:733705 1624291 (PMID:10644691), (PMID:12154096), (PMID:12937339), (PMID:18193033), (PMID:19187541) RGD PMID:10644691 more ... canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:6284231 , PMID:30478225 canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation ISO RGD:1550466 1624291 (MGI:MGI:2446944, PMID:12464179) RGD MGI:MGI:2446944 , PMID:12464179 canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition ISO RGD:733705 1624291 (PMID:17072303) RGD PMID:17072303 canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell adhesion ISO RGD:733705 1624291 (PMID:19101069) RGD PMID:19101069 cell adhesion ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell adhesion NAS 10395276 PMID:12610652 ARUK-UCL cell differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3051737 more ... cell fate determination ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3529734 , PMID:15708565 cell fate specification ISO RGD:1550466 1624291 MGI:MGI:2148591 more ... RGD MGI:MGI:3578464 , PMID:15866163 cell fate specification IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell maturation ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3511731 more ... cell maturation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell morphogenesis involved in differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3603687 , PMID:16102745 cell morphogenesis involved in differentiation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell population proliferation ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3051737 , PMID:15131783) RGD MGI:MGI:3051737 , PMID:15131783 cell-cell adhesion IDA 1626295 RGD cell-cell adhesion IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell-cell adhesion ISS UniProtKB:Q9UI47 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell-cell adhesion ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3603687 , PMID:16102745 cell-cell adhesion IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell-cell adhesion TAS 8554709 PMID:20299672 DFLAT cell-cell adhesion ISO RGD:733705 1624291 (PMID:18593713) RGD PMID:18593713 cell-matrix adhesion ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3051737 , PMID:15131783) RGD MGI:MGI:3051737 , PMID:15131783 cell-matrix adhesion IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 cellular process ISO RGD:1550466 1624291 (MGI:MGI:2662628, PMID:12717450) RGD MGI:MGI:2662628 , PMID:12717450 cellular protein localization ISO RGD:1550466 1624291 (MGI:MGI:3689461, PMID:16621792) RGD MGI:MGI:3689461 , PMID:16621792 cellular response to fibroblast growth factor stimulus IEP 728475 RGD cellular response to growth factor stimulus ISO RGD:733705 1624291 (PMID:16858403) RGD PMID:16858403 cellular response to growth factor stimulus IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 cellular response to growth factor stimulus ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cellular response to indole-3-methanol ISO RGD:733705 1624291 (PMID:10868478) RGD PMID:10868478 cellular response to indole-3-methanol IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 cellular response to indole-3-methanol ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cellular response to insulin-like growth factor stimulus IMP 7242068 RGD cellular response to insulin-like growth factor stimulus IEP 7242068 RGD cellular response to lithium ion IEP 10395276 RGD cellular response to mechanical stimulus IDA 7242068 RGD central nervous system vasculogenesis ISO RGD:1550466 1624291 MGI:MGI:2148569 (MGI:MGI:3821408 , PMID:19023080) RGD MGI:MGI:3821408 , PMID:19023080 central nervous system vasculogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 chemical synaptic transmission ISO RGD:1550466 1624291 MGI:MGI:2148594 (MGI:MGI:2680876 , PMID:14622577) RGD MGI:MGI:2680876 , PMID:14622577 chemical synaptic transmission IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 chromatin-mediated maintenance of transcription ISO RGD:1550466 1624291 (MGI:MGI:5428344, PMID:22723415) RGD MGI:MGI:5428344 , PMID:22723415 chromatin-mediated maintenance of transcription IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 cranial ganglion development ISO RGD:1550466 1624291 (MGI:MGI:1931800, PMID:11262227) RGD MGI:MGI:1931800 , PMID:11262227 cranial ganglion development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 cranial skeletal system development ISO RGD:1550466 1624291 (MGI:MGI:1931800, PMID:11262227) RGD MGI:MGI:1931800 , PMID:11262227 cranial skeletal system development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 dorsal root ganglion development ISO RGD:1550466 1624291 (MGI:MGI:1931800, PMID:11262227) RGD MGI:MGI:1931800 , PMID:11262227 dorsal root ganglion development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 dorsal/ventral axis specification ISO RGD:1550466 1624291 MGI:MGI:2148594 more ... RGD MGI:MGI:2670493 , PMID:12923052 dorsal/ventral axis specification IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 dorsal/ventral pattern formation ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3529734 , PMID:15708565 ectoderm development ISO RGD:1550466 1624291 MGI:MGI:1857678 (MGI:MGI:77405 , PMID:8582267) RGD MGI:MGI:77405 , PMID:8582267 ectoderm development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic axis specification ISO RGD:1550466 1624291 (MGI:MGI:894149, PMID:9230313) RGD MGI:MGI:894149 , PMID:9230313 embryonic axis specification IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic brain development ISO RGD:1550466 1624291 (MGI:MGI:1931800, PMID:11262227) RGD MGI:MGI:1931800 , PMID:11262227 embryonic brain development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic digit morphogenesis ISO RGD:1550466 1624291 MGI:MGI:1338938 more ... RGD MGI:MGI:2670493 more ... embryonic digit morphogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic foregut morphogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3820452 , PMID:18692041) RGD MGI:MGI:3820452 , PMID:18692041 embryonic foregut morphogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic forelimb morphogenesis ISO RGD:1550466 1624291 (MGI:MGI:3055626, PMID:15371327) RGD MGI:MGI:3055626 , PMID:15371327 embryonic forelimb morphogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic heart tube development ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3773938 , PMID:18231602) RGD MGI:MGI:3773938 , PMID:18231602 embryonic heart tube development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic hindlimb morphogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:2670493 more ... embryonic hindlimb morphogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 embryonic organ development ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:6284231 , PMID:30478225 embryonic skeletal limb joint morphogenesis ISO RGD:1550466 1624291 UniProtKB:Q91ZD1 (MGI:MGI:4950000 , PMID:21262216) RGD MGI:MGI:4950000 , PMID:21262216 embryonic skeletal limb joint morphogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 endoderm formation ISO RGD:1550466 1624291 MGI:MGI:1858007 more ... RGD MGI:MGI:3625553 more ... endodermal cell fate commitment ISO RGD:1550466 1624291 MGI:MGI:1858007 more ... RGD MGI:MGI:3625553 , PMID:12194849 endodermal cell fate commitment IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 endothelial tube morphogenesis ISO RGD:733705 1624291 (PMID:20123964) RGD PMID:20123964 endothelial tube morphogenesis IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 endothelial tube morphogenesis ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 epithelial cell differentiation involved in prostate gland development ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:2667427 , PMID:12813461) RGD MGI:MGI:2667427 , PMID:12813461 epithelial cell differentiation involved in prostate gland development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 epithelial tube branching involved in lung morphogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3773938 , PMID:18231602) RGD MGI:MGI:3773938 , PMID:18231602 epithelial tube branching involved in lung morphogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 forebrain development ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3529734 , PMID:15708565 fungiform papilla formation ISO RGD:1550466 1624291 (MGI:MGI:3696593, PMID:17128274) RGD MGI:MGI:3696593 , PMID:17128274 fungiform papilla formation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 gastrulation with mouth forming second ISO RGD:1550466 1624291 MGI:MGI:1857678 (MGI:MGI:77405 , PMID:8582267) RGD MGI:MGI:77405 , PMID:8582267 gastrulation with mouth forming second IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 genitalia morphogenesis ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:3807613 , PMID:18635608) RGD MGI:MGI:3807613 , PMID:18635608 genitalia morphogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 glial cell fate determination ISO RGD:1550466 1624291 (MGI:MGI:3722716, PMID:17706960) RGD MGI:MGI:3722716 , PMID:17706960 glial cell fate determination IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 hair cycle process ISO RGD:1550466 1624291 MGI:MGI:2148594 more ... RGD MGI:MGI:1934694 , PMID:11371349 hair follicle morphogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:1934694 more ... hair follicle morphogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 hair follicle placode formation ISO RGD:1550466 1624291 MGI:MGI:1195272 more ... RGD MGI:MGI:1934694 more ... hair follicle placode formation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 heart development ISO RGD:1550466 1624291 MGI:MGI:2148569 (MGI:MGI:2446944 , PMID:12464179) RGD MGI:MGI:2446944 , PMID:12464179 hemopoiesis ISO RGD:1550466 1624291 (MGI:MGI:2662628, PMID:12717450) RGD MGI:MGI:2662628 , PMID:12717450 hindbrain development ISO RGD:1550466 1624291 (MGI:MGI:1931800, PMID:11262227) RGD MGI:MGI:1931800 , PMID:11262227 hindbrain development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 in utero embryonic development ISO RGD:1550466 1624291 MGI:MGI:1096327 more ... RGD MGI:MGI:3773938 more ... in utero embryonic development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 kidney development ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:3714576 , PMID:17537789) RGD MGI:MGI:3714576 , PMID:17537789 layer formation in cerebral cortex ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:4454697 , PMID:20503375 layer formation in cerebral cortex IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 lens morphogenesis in camera-type eye ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3603687 , PMID:16102745 lens morphogenesis in camera-type eye IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 limb development ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:2450015 , PMID:12569130) RGD MGI:MGI:2450015 , PMID:12569130 liver development IEP 1599633 RGD lung cell differentiation ISO RGD:1550466 1624291 MGI:MGI:2148569 (MGI:MGI:4361775 , PMID:19805295) RGD MGI:MGI:4361775 , PMID:19805295 lung cell differentiation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 lung development ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:2677587 more ... lung induction ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:4360856 more ... lung induction IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 lung-associated mesenchyme development ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3801531 , PMID:18533146) RGD MGI:MGI:3801531 , PMID:18533146 lung-associated mesenchyme development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 male genitalia development ISO RGD:1550466 1624291 MGI:MGI:2148594 (MGI:MGI:3845460 , PMID:19282366) RGD MGI:MGI:3845460 , PMID:19282366 male genitalia development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 mesenchymal cell proliferation involved in lung development ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3696593 more ... RGD MGI:MGI:3696593 more ... mesenchymal cell proliferation involved in lung development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 metanephros morphogenesis ISO RGD:1550466 1624291 (MGI:MGI:3821953, PMID:19060336) RGD MGI:MGI:3821953 , PMID:19060336 metanephros morphogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 midbrain development ISO RGD:1550466 1624291 (MGI:MGI:1931800, PMID:11262227) RGD MGI:MGI:1931800 , PMID:11262227 midbrain dopaminergic neuron differentiation ISO RGD:1550466 1624291 (MGI:MGI:3836885, PMID:19122665) RGD MGI:MGI:3836885 , PMID:19122665 midbrain dopaminergic neuron differentiation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 midgut development IEP 2289844 RGD morphogenesis of embryonic epithelium ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3603687 , PMID:16102745 myoblast differentiation IEP 1599634 RGD negative regulation of angiogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of angiogenesis ISO RGD:1550466 1624291 (MGI:MGI:5883199, PMID:25961718) RGD MGI:MGI:5883199 , PMID:25961718 negative regulation of apoptotic process ISO RGD:733705 1624291 (PMID:12154096) RGD PMID:12154096 negative regulation of apoptotic signaling pathway ISO RGD:1550466 1624291 MGI:MGI:1858008 more ... RGD MGI:MGI:3051737 more ... negative regulation of apoptotic signaling pathway IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of cell differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3578464 more ... negative regulation of cell population proliferation ISO RGD:733705 1624291 (PMID:12970740) RGD PMID:12970740 negative regulation of cell population proliferation IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of cell population proliferation ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 negative regulation of chondrocyte differentiation ISO RGD:1550466 1624291 MGI:MGI:2446084 (MGI:MGI:3701031 , PMID:16818445) RGD MGI:MGI:3701031 , PMID:16818445 negative regulation of chondrocyte differentiation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of gene expression ISO RGD:1550466 1624291 (MGI:MGI:3836885, PMID:19122665) RGD MGI:MGI:3836885 , PMID:19122665 negative regulation of gene expression IMP 13210526 PMID:23270756 BHF-UCL negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis ISO RGD:1550466 1624291 (MGI:MGI:3714576, PMID:17537789) RGD MGI:MGI:3714576 , PMID:17537789 negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of mitotic cell cycle, embryonic ISO RGD:1550466 1624291 (MGI:MGI:4941059, PMID:21325504) RGD MGI:MGI:4941059 , PMID:21325504 negative regulation of mitotic cell cycle, embryonic ISS UniProtKB:Q02248 1600115 GO_REF:0000024 UniProt GO_REF:0000024 negative regulation of mitotic cell cycle, embryonic IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of neurogenesis ISO RGD:1550466 1624291 (MGI:MGI:5699500, PMID:26371318) RGD MGI:MGI:5699500 , PMID:26371318 negative regulation of neuron death ISO RGD:1550466 1624291 MGI:MGI:2135607 (MGI:MGI:5437773 , PMID:22956852) RGD MGI:MGI:5437773 , PMID:22956852 negative regulation of oligodendrocyte differentiation ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:4359141 , PMID:19503085) RGD MGI:MGI:4359141 , PMID:19503085 negative regulation of oligodendrocyte differentiation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of osteoclast differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3578468 , PMID:15866165 negative regulation of osteoclast differentiation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of oxidative stress-induced neuron death ISO RGD:1550466 1624291 (MGI:MGI:5770063, PMID:21752258) RGD MGI:MGI:5770063 , PMID:21752258 negative regulation of oxidative stress-induced neuron death IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of protein sumoylation ISO RGD:733705 1624291 (PMID:22155184) RGD PMID:22155184 negative regulation of protein sumoylation IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of protein sumoylation ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 negative regulation of transcription by RNA polymerase II IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of transcription by RNA polymerase II ISO RGD:1550466 1624291 (MGI:MGI:3613282, PMID:16040629) RGD MGI:MGI:3613282 , PMID:16040629 negative regulation of transcription, DNA-templated ISO RGD:733705 1624291 (PMID:19653274) RGD PMID:19653274 negative regulation of transcription, DNA-templated ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 negative regulation of transcription, DNA-templated ISO RGD:1550466 1624291 MGI:MGI:2148594 (MGI:MGI:2655026 more ... RGD MGI:MGI:2655026 more ... nephron tubule formation ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:3714576 , PMID:17537789) RGD MGI:MGI:3714576 , PMID:17537789 nephron tubule formation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 neural plate development ISO RGD:1550466 1624291 (MGI:MGI:5302997, PMID:22102609) RGD MGI:MGI:5302997 , PMID:22102609 neural plate development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 neuron differentiation ISO RGD:1550466 1624291 (MGI:MGI:5689084, PMID:25009587) RGD MGI:MGI:5689084 , PMID:25009587 neuron migration ISO RGD:1550466 1624291 MGI:MGI:1334448 (MGI:MGI:5294271 , PMID:21937711) RGD MGI:MGI:5294271 , PMID:21937711 neuron migration IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 neuron projection extension ISO RGD:733705 1624291 (PMID:19830702) RGD PMID:19830702 neuron projection extension IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 neuron projection extension ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 odontogenesis of dentin-containing tooth IEP 2289810 RGD odontogenesis of dentin-containing tooth IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 odontogenesis of dentin-containing tooth ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:3578468 , PMID:15866165) RGD MGI:MGI:3578468 , PMID:15866165 oocyte development ISO RGD:1550466 1624291 MGI:MGI:98957 (MGI:MGI:4454604 , PMID:20454446) RGD MGI:MGI:4454604 , PMID:20454446 oocyte development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 osteoclast differentiation ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:3578468 , PMID:15866165) RGD MGI:MGI:3578468 , PMID:15866165 osteoclast differentiation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 oviduct development ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3716048 , PMID:17532316 oviduct development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 pancreas development ISO RGD:1550466 1624291 MGI:MGI:2148569 (MGI:MGI:3607950 , PMID:16192304) RGD MGI:MGI:3607950 , PMID:16192304 pancreas development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of apoptotic process ISO RGD:733705 1624291 (PMID:12651860), (PMID:12970740) RGD PMID:12651860 , PMID:12970740 positive regulation of apoptotic process ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of branching involved in lung morphogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3801531 , PMID:18533146) RGD MGI:MGI:3801531 , PMID:18533146 positive regulation of cell population proliferation ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:4359548 , PMID:19690384 positive regulation of chromatin-mediated maintenance of transcription ISO RGD:1550466 1624291 (MGI:MGI:5428344, PMID:22723415) RGD MGI:MGI:5428344 , PMID:22723415 positive regulation of chromatin-mediated maintenance of transcription IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of core promoter binding IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of core promoter binding IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of core promoter binding ISO RGD:733705 1624291 (PMID:22723415) RGD PMID:22723415 positive regulation of core promoter binding ISO RGD:1550466 1624291 (MGI:MGI:5428344, PMID:22723415) RGD MGI:MGI:5428344 , PMID:22723415 positive regulation of determination of dorsal identity ISO RGD:1550466 1624291 (MGI:MGI:3797993, PMID:18316368) RGD MGI:MGI:3797993 , PMID:18316368 positive regulation of determination of dorsal identity IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of DNA-binding transcription factor activity ISO RGD:1550466 1624291 (MGI:MGI:5700307, PMID:15905404) RGD MGI:MGI:5700307 , PMID:15905404 positive regulation of DNA-binding transcription factor activity IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of DNA-binding transcription factor activity IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of DNA-binding transcription factor activity ISO RGD:733705 1624291 (PMID:15905404) RGD PMID:15905404 positive regulation of DNA-templated transcription, initiation ISO RGD:1550466 1624291 (MGI:MGI:5428344, PMID:22723415) RGD MGI:MGI:5428344 , PMID:22723415 positive regulation of DNA-templated transcription, initiation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of endothelial cell differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3773938 , PMID:18231602) RGD MGI:MGI:3773938 , PMID:18231602 positive regulation of endothelial cell differentiation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of epithelial cell differentiation ISO RGD:1550466 1624291 MGI:MGI:1858008 more ... RGD MGI:MGI:3613282 , PMID:16040629 positive regulation of epithelial cell proliferation involved in prostate gland development ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:2667427 , PMID:12813461) RGD MGI:MGI:2667427 , PMID:12813461 positive regulation of epithelial cell proliferation involved in prostate gland development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of epithelial to mesenchymal transition ISO RGD:733705 1624291 UniProtKB:Q9NX18 (PMID:23983127) RGD PMID:23983127 positive regulation of fibroblast growth factor receptor signaling pathway ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3773938 more ... RGD MGI:MGI:3773938 more ... positive regulation of fibroblast growth factor receptor signaling pathway IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of gene expression ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3773938 more ... positive regulation of heparan sulfate proteoglycan biosynthetic process ISO RGD:733705 1624291 (PMID:15853773) RGD PMID:15853773 positive regulation of heparan sulfate proteoglycan biosynthetic process IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of heparan sulfate proteoglycan biosynthetic process ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of I-kappaB kinase/NF-kappaB signaling ISO RGD:1550466 1624291 (MGI:MGI:4355652, PMID:19619491) RGD MGI:MGI:4355652 , PMID:19619491 positive regulation of I-kappaB kinase/NF-kappaB signaling IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of MAPK cascade ISO RGD:1550466 1624291 MGI:MGI:88039 (MGI:MGI:3618985 , PMID:16478791) RGD MGI:MGI:3618985 , PMID:16478791 positive regulation of MAPK cascade IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of mesenchymal cell proliferation ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3773938 more ... RGD MGI:MGI:3773938 more ... positive regulation of mesenchymal cell proliferation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of neural precursor cell proliferation ISO RGD:1550466 1624291 (MGI:MGI:5699500, PMID:26371318) RGD MGI:MGI:5699500 , PMID:26371318 positive regulation of neuroblast proliferation ISO RGD:1550466 1624291 MGI:MGI:1334448 (MGI:MGI:4941059 more ... RGD MGI:MGI:4941059 more ... positive regulation of neuroblast proliferation ISS UniProtKB:Q02248 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of neuroblast proliferation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of neuron apoptotic process ISO RGD:733705 1624291 (PMID:19591802) RGD PMID:19591802 positive regulation of neuron apoptotic process IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of osteoblast differentiation ISO RGD:1550466 1624291 MGI:MGI:2148591 more ... RGD MGI:MGI:3578464 , PMID:15866163 positive regulation of osteoblast differentiation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of skeletal muscle tissue development ISO RGD:1550466 1624291 (MGI:MGI:5619733, PMID:23460868) RGD MGI:MGI:5619733 , PMID:23460868 positive regulation of skeletal muscle tissue development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of telomerase activity ISO RGD:1550466 1624291 (MGI:MGI:5428344, PMID:22723415) RGD MGI:MGI:5428344 , PMID:22723415 positive regulation of telomerase activity IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of telomere maintenance via telomerase ISO RGD:1550466 1624291 (MGI:MGI:5428344, PMID:22723415) RGD MGI:MGI:5428344 , PMID:22723415 positive regulation of telomere maintenance via telomerase IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of transcription by RNA polymerase II ISO RGD:733705 1624291 (PMID:11751639), (PMID:12651860), (PMID:14660579), (PMID:15592430), (PMID:18193033), (PMID:19328798), (PMID:22723415), (PMID:9065402) RGD PMID:11751639 more ... positive regulation of transcription by RNA polymerase II ISO RGD:1550466 1624291 MGI:MGI:104554 more ... RGD MGI:MGI:3038034 more ... positive regulation of transcription by RNA polymerase II IBA FB:FBgn0000117 more ... 13792537 PMID:21873635 GO_Central positive regulation of transcription by RNA polymerase II IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of transcription by RNA polymerase II ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of transcription by RNA polymerase II IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of transcription elongation from RNA polymerase II promoter ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:6284231 , PMID:30478225 positive regulation of transcription, DNA-templated ISO RGD:733705 1624291 (PMID:12949260), (PMID:12970740), (PMID:18787224) RGD PMID:12949260 more ... positive regulation of transcription, DNA-templated ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of transcription, DNA-templated ISO RGD:1550466 1624291 MGI:MGI:1858008 more ... RGD MGI:MGI:1351293 more ... proteasome-mediated ubiquitin-dependent protein catabolic process IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 proteasome-mediated ubiquitin-dependent protein catabolic process ISO RGD:733705 1624291 (PMID:29374064) RGD PMID:29374064 protein localization to cell surface ISO RGD:733705 1624291 (PMID:20086044) RGD PMID:20086044 protein localization to cell surface IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein localization to cell surface ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 protein polyubiquitination IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein polyubiquitination ISO RGD:733705 1624291 (PMID:29374064) RGD PMID:29374064 proximal/distal pattern formation ISO RGD:1550466 1624291 MGI:MGI:2148594 (MGI:MGI:2677587 , PMID:12885771) RGD MGI:MGI:2677587 , PMID:12885771 proximal/distal pattern formation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of apoptotic process ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:4430000 , PMID:20043884) RGD MGI:MGI:4430000 , PMID:20043884 regulation of calcium ion import ISO RGD:733705 1624291 (PMID:19996314) RGD PMID:19996314 regulation of calcium ion import IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of calcium ion import ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 regulation of cell differentiation ISO RGD:1550466 1624291 (MGI:MGI:2662628, PMID:12717450) RGD MGI:MGI:2662628 , PMID:12717450 regulation of cell population proliferation ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:2386811 more ... RGD MGI:MGI:2386811 more ... regulation of centriole-centriole cohesion ISO RGD:733705 1624291 (PMID:18086858) RGD PMID:18086858 regulation of centriole-centriole cohesion IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of centriole-centriole cohesion ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 regulation of centromeric sister chromatid cohesion ISO RGD:1550466 1624291 (MGI:MGI:4835108, PMID:20300119) RGD MGI:MGI:4835108 , PMID:20300119 regulation of centromeric sister chromatid cohesion IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of centromeric sister chromatid cohesion ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 regulation of centromeric sister chromatid cohesion IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of centromeric sister chromatid cohesion ISO RGD:733705 1624291 (PMID:20300119) RGD PMID:20300119 regulation of core promoter binding ISO RGD:1550466 1624291 (MGI:MGI:5428344, PMID:22723415) RGD MGI:MGI:5428344 , PMID:22723415 regulation of epithelial cell differentiation ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:2667427 , PMID:12813461) RGD MGI:MGI:2667427 , PMID:12813461 regulation of euchromatin binding ISO RGD:1550466 1624291 (MGI:MGI:5428344, PMID:22723415) RGD MGI:MGI:5428344 , PMID:22723415 regulation of euchromatin binding IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of gene expression ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:5302997 , PMID:22102609) RGD MGI:MGI:5302997 , PMID:22102609 regulation of myelination ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:3849618 , PMID:19515974) RGD MGI:MGI:3849618 , PMID:19515974 regulation of myelination IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of nephron tubule epithelial cell differentiation ISO RGD:1550466 1624291 (MGI:MGI:3822373, PMID:19112489) RGD MGI:MGI:3822373 , PMID:19112489 regulation of nephron tubule epithelial cell differentiation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of osteoblast differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:3511731 more ... regulation of osteoclast differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3584206 , PMID:15802266) RGD MGI:MGI:3584206 , PMID:15802266 regulation of protein localization to cell surface ISO RGD:733705 1624291 (PMID:19996314) RGD PMID:19996314 regulation of protein localization to cell surface IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of protein localization to cell surface ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 regulation of secondary heart field cardioblast proliferation ISO RGD:1550466 1624291 (MGI:MGI:4438134, PMID:19620969) RGD MGI:MGI:4438134 , PMID:19620969 regulation of secondary heart field cardioblast proliferation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of smooth muscle cell proliferation ISO RGD:733705 1624291 (PMID:17122440) RGD PMID:17122440 regulation of smooth muscle cell proliferation IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of smooth muscle cell proliferation ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 regulation of T cell proliferation ISO RGD:1550466 1624291 MGI:MGI:2148594 more ... RGD MGI:MGI:2680853 , PMID:14608382 regulation of T cell proliferation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of timing of anagen IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of timing of anagen ISO RGD:1550466 1624291 (MGI:MGI:5571208, PMID:24681597) RGD MGI:MGI:5571208 , PMID:24681597 regulation of transcription by RNA polymerase II ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:2386811 more ... RGD MGI:MGI:2386811 more ... renal inner medulla development ISO RGD:1550466 1624291 (MGI:MGI:3821953, PMID:19060336) RGD MGI:MGI:3821953 , PMID:19060336 renal inner medulla development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 renal outer medulla development ISO RGD:1550466 1624291 (MGI:MGI:3821953, PMID:19060336) RGD MGI:MGI:3821953 , PMID:19060336 renal outer medulla development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 renal vesicle formation ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:3714576 , PMID:17537789) RGD MGI:MGI:3714576 , PMID:17537789 renal vesicle formation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to activity IEP 10045362 RGD response to cadmium ion IEP 1598557 RGD response to cytokine IDA 2289841 RGD response to drug ISO RGD:733705 1624291 (PMID:18291362) RGD PMID:18291362 response to drug IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to estradiol IEP 10045362 RGD response to estradiol IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to estradiol ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 response to estradiol ISO RGD:733705 1624291 (PMID:15304487) RGD PMID:15304487 response to estrogen IDA 1599635 RGD response to hormone IEP 2289842 RGD response to organic cyclic compound IEP 2289838 RGD Schwann cell proliferation IMP 2289839 RGD skeletal system development ISO RGD:1550466 1624291 MGI:MGI:2148591 more ... RGD MGI:MGI:3578464 , PMID:15866163 skin development ISO RGD:1550466 1624291 MGI:MGI:2148594 (MGI:MGI:4412144 , PMID:19718027) RGD MGI:MGI:4412144 , PMID:19718027 smooth muscle cell differentiation ISO RGD:1550466 1624291 MGI:MGI:2148567 more ... RGD MGI:MGI:4359548 , PMID:19690384 smooth muscle cell differentiation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 sympathetic ganglion development ISO RGD:1550466 1624291 (MGI:MGI:4941059, PMID:21325504) RGD MGI:MGI:4941059 , PMID:21325504 sympathetic ganglion development ISS UniProtKB:Q02248 1600115 GO_REF:0000024 UniProt GO_REF:0000024 sympathetic ganglion development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 synapse organization ISO RGD:1550466 1624291 MGI:MGI:2148594 (MGI:MGI:2680876 , PMID:14622577) RGD MGI:MGI:2680876 , PMID:14622577 synapse organization IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 synaptic vesicle clustering IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 synaptic vesicle clustering ISO RGD:1550466 1624291 (MGI:MGI:2680876, PMID:14622577) RGD MGI:MGI:2680876 , PMID:14622577 synaptic vesicle transport ISO RGD:1550466 1624291 MGI:MGI:2148594 (MGI:MGI:2680876 , PMID:14622577) RGD MGI:MGI:2680876 , PMID:14622577 synaptic vesicle transport IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 T cell differentiation ISO RGD:1550466 1624291 MGI:MGI:2148594 more ... RGD MGI:MGI:2680853 , PMID:14608382 T cell differentiation in thymus ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:3588595 , PMID:16025118) RGD MGI:MGI:3588595 , PMID:16025118 T cell differentiation in thymus IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 thymus development ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:3588595 , PMID:16025118) RGD MGI:MGI:3588595 , PMID:16025118 thymus development IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 tissue homeostasis ISO RGD:1550466 1624291 MGI:MGI:1858008 (MGI:MGI:3807613 , PMID:18635608) RGD MGI:MGI:3807613 , PMID:18635608 trachea formation ISO RGD:1550466 1624291 MGI:MGI:2148569 (MGI:MGI:4361775 , PMID:19805295) RGD MGI:MGI:4361775 , PMID:19805295 trachea formation IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 trachea morphogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3773938 more ... RGD MGI:MGI:3773938 more ... vasculature development ISO RGD:1550466 1624291 (MGI:MGI:3829282, PMID:19129494) RGD MGI:MGI:3829282 , PMID:19129494 vasculogenesis ISO RGD:1550466 1624291 MGI:MGI:2148567 (MGI:MGI:3773938 , PMID:18231602) RGD MGI:MGI:3773938 , PMID:18231602 Cellular Component adherens junction IDA 1626295 ; 2291902 RGD adherens junction IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 adherens junction IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 adherens junction ISO RGD:733705 1624291 (PMID:10403777), (PMID:18086858), (PMID:19101069), (PMID:20086044), (PMID:22855531) RGD PMID:10403777 more ... adherens junction IBA FB:FBgn0000117 more ... 13792537 PMID:21873635 GO_Central adherens junction ISO RGD:1550466 1624291 (MGI:MGI:2154851 more ... RGD MGI:MGI:2154851 more ... apical junction complex ISO RGD:1550466 1624291 (MGI:MGI:3610718 more ... RGD MGI:MGI:3610718 more ... apical part of cell ISO RGD:1550466 1624291 (MGI:MGI:3033551 more ... RGD MGI:MGI:3033551 more ... apical part of cell IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 apicolateral plasma membrane ISO RGD:1550466 1624291 (MGI:MGI:6103256, PMID:29211732) RGD MGI:MGI:6103256 , PMID:29211732 basolateral plasma membrane ISO RGD:733705 1624291 (PMID:24862762) RGD PMID:24862762 basolateral plasma membrane IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 basolateral plasma membrane IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 basolateral plasma membrane ISO RGD:1550466 1624291 (MGI:MGI:1331308 more ... RGD MGI:MGI:1331308 more ... beta-catenin destruction complex ISO RGD:1550466 1624291 (MGI:MGI:1336856, PMID:10318824) RGD MGI:MGI:1336856 , PMID:10318824 beta-catenin destruction complex IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 beta-catenin destruction complex ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 beta-catenin destruction complex IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 beta-catenin destruction complex ISO RGD:733705 1624291 (PMID:16188939), (PMID:8638126) RGD PMID:16188939 , PMID:8638126 beta-catenin-TCF complex ISO RGD:733705 1624291 UniProtKB:O00512 more ... RGD PMID:11955446 more ... beta-catenin-TCF complex ISO RGD:1550466 1624291 (MGI:MGI:1196720 more ... RGD MGI:MGI:1196720 more ... beta-catenin-TCF7L2 complex ISO RGD:733705 1624291 (PMID:12651860), (PMID:9065401), (PMID:9065402) RGD PMID:12651860 more ... beta-catenin-TCF7L2 complex IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 beta-catenin-TCF7L2 complex ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 bicellular tight junction ISO RGD:1550466 1624291 (MGI:MGI:3696284, PMID:17130295) RGD MGI:MGI:3696284 , PMID:17130295 bicellular tight junction IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 catenin complex ISO RGD:1550466 1624291 UniProtKB:P09803 more ... RGD MGI:MGI:5882917 more ... catenin complex IBA FB:FBgn0000117 more ... 13792537 PMID:21873635 GO_Central catenin complex ISO RGD:733705 1624291 (PMID:18593713), (PMID:20302655), (PMID:28051089), (PMID:7650039) RGD PMID:18593713 more ... catenin complex IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 catenin complex ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 catenin complex IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 cell cortex ISO RGD:733705 1624291 (PMID:19038973) RGD PMID:19038973 cell cortex ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell junction ISO RGD:733705 1624291 (PMID:19038973), (PMID:20412773) RGD PMID:19038973 , PMID:20412773 cell junction ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell periphery ISO RGD:733705 1624291 (PMID:19038973) RGD PMID:19038973 cell periphery ISS UniProtKB:P35222 1600115 GO_REF:0000024 BHF-UCL GO_REF:0000024 cell projection membrane ISO RGD:1550466 1624291 (MGI:MGI:3689461, PMID:16621792) RGD MGI:MGI:3689461 , PMID:16621792 cell-cell junction ISO RGD:12299678 1624291 (PMID:10873669) RGD PMID:10873669 cell-cell junction ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell-cell junction ISS UniProtKB:B6V8E6 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cell-cell junction ISO RGD:733705 1624291 (PMID:19151727), (PMID:19996314) RGD PMID:19151727 , PMID:19996314 cell-cell junction ISO RGD:1550466 1624291 (MGI:MGI:1331308 more ... RGD MGI:MGI:1331308 more ... centrosome ISO RGD:1550466 1624291 (MGI:MGI:4835108, PMID:20300119) RGD MGI:MGI:4835108 , PMID:20300119 centrosome IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 centrosome ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 centrosome IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 centrosome ISO RGD:733705 1624291 (PMID:18086858), (PMID:20300119) RGD PMID:18086858 , PMID:20300119 cytoplasm TAS 70260 RGD cytoplasm ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cytoplasm IDA 10395276 PMID:12610652 ARUK-UCL cytoplasm ISO RGD:733705 1624291 (PMID:11793365), (PMID:12138115), (PMID:12937339), (PMID:12970740), (PMID:18787224), (PMID:19095296), (PMID:19591802), (PMID:22467863), (PMID:29739711), (PMID:7806582), (PMID:9707618) RGD PMID:11793365 more ... cytoplasm ISO RGD:1550466 1624291 (MGI:MGI:2154850 more ... RGD MGI:MGI:2154850 more ... cytosol IDA 1599635 RGD cytosol IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 cytosol IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 cytosol ISO RGD:1550466 1624291 (MGI:MGI:2385552 more ... RGD MGI:MGI:2385552 more ... cytosol ISO RGD:733705 1624291 (PMID:10980594), (PMID:19187541) RGD PMID:10980594 , PMID:19187541 dendritic shaft IDA 1299225 RGD exocytic vesicle ISO RGD:12299678 1624291 (PMID:18504258) RGD PMID:18504258 fascia adherens ISO RGD:1550466 1624291 (MGI:MGI:3656458, PMID:16481394) RGD MGI:MGI:3656458 , PMID:16481394 fascia adherens IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 flotillin complex ISO RGD:1550466 1624291 (MGI:MGI:5634880, PMID:24046456) RGD MGI:MGI:5634880 , PMID:24046456 flotillin complex IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 intercalated disc IDA 13524855 RGD intercalated disc ISO RGD:1550466 1624291 (MGI:MGI:3720394, PMID:17535849) RGD MGI:MGI:3720394 , PMID:17535849 lamellipodium ISO RGD:1550466 1624291 (MGI:MGI:3028451, PMID:14657280) RGD MGI:MGI:3028451 , PMID:14657280 lamellipodium IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 lateral plasma membrane ISO RGD:1550466 1624291 (MGI:MGI:3528104, PMID:15645444) RGD MGI:MGI:3528104 , PMID:15645444 lateral plasma membrane IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 lateral plasma membrane IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 lateral plasma membrane ISO RGD:733705 1624291 (PMID:12072559), (PMID:22855531) RGD PMID:12072559 , PMID:22855531 membrane IDA 8553932 PMID:16815997 UniProt membrane ISO RGD:1550466 1624291 (MGI:MGI:2154850 more ... RGD MGI:MGI:2154850 more ... microvillus membrane ISO RGD:1550466 1624291 (MGI:MGI:3617131, PMID:16439479) RGD MGI:MGI:3617131 , PMID:16439479 microvillus membrane IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 neuron projection colocalizes_with IDA 1599286 RGD nuclear euchromatin ISO RGD:733705 1624291 (PMID:22723415) RGD PMID:22723415 nuclear euchromatin IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 nuclear euchromatin IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 nuclear euchromatin ISO RGD:1550466 1624291 (MGI:MGI:5428344, PMID:22723415) RGD MGI:MGI:5428344 , PMID:22723415 nuclear membrane IDA 10395276 PMID:12610652 ARUK-UCL nucleus IDA 1599635 RGD nucleus IDA 15023472 PMID:16690606 CACAO nucleus IDA 11079190 PMID:20097766 CACAO nucleus ISO RGD:1550466 1624291 (MGI:MGI:2154850 more ... RGD MGI:MGI:2154850 more ... nucleus IDA 12790651 PMID:16805831 ARUK-UCL nucleus ISO RGD:733705 1624291 (PMID:10980594), (PMID:15040835), (PMID:16858403), (PMID:18193033), (PMID:18756595), (PMID:18787224), (PMID:19095296), (PMID:19187541), (PMID:28829046), (PMID:29367600), (PMID:29739711), (PMID:9707618) RGD PMID:10980594 more ... perinuclear region of cytoplasm IDA 7242068 RGD perinuclear region of cytoplasm IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 perinuclear region of cytoplasm ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 perinuclear region of cytoplasm ISO RGD:733705 1624291 (PMID:19038973) RGD PMID:19038973 plasma membrane ISO RGD:12299678 1624291 (PMID:8636221) RGD PMID:8636221 plasma membrane ISO RGD:1550466 1624291 (MGI:MGI:2180453 more ... RGD MGI:MGI:2180453 more ... plasma membrane ISO RGD:733705 1624291 (PMID:12138115), (PMID:12970740) RGD GO_REF:0000052 more ... plasma membrane ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 plasma membrane IDA 10395276 PMID:12610652 ARUK-UCL postsynaptic density, intracellular component IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 postsynaptic density, intracellular component ISO RGD:1550466 1624291 (MGI:MGI:83903, PMID:8909549) RGD MGI:MGI:83903 , PMID:8909549 postsynaptic membrane IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 postsynaptic membrane ISO RGD:1550466 1624291 (MGI:MGI:83903, PMID:8909549) RGD MGI:MGI:83903 , PMID:8909549 presynaptic active zone cytoplasmic component IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 presynaptic active zone cytoplasmic component ISO RGD:1550466 1624291 (MGI:MGI:83903, PMID:8909549) RGD MGI:MGI:83903 , PMID:8909549 presynaptic membrane IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 presynaptic membrane ISO RGD:1550466 1624291 (MGI:MGI:83903, PMID:8909549) RGD MGI:MGI:83903 , PMID:8909549 protein-containing complex IDA 1626295 RGD protein-containing complex ISO RGD:733705 1624291 (PMID:22083958) RGD PMID:22083958 protein-DNA complex ISO RGD:733705 1624291 (PMID:10825188) RGD PMID:10825188 protein-DNA complex IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein-DNA complex ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 Schaffer collateral - CA1 synapse IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 Schaffer collateral - CA1 synapse ISO RGD:1550466 1624291 (MGI:MGI:2680876, PMID:14622577) RGD MGI:MGI:2680876 , PMID:14622577 Scrib-APC-beta-catenin complex ISO RGD:1550466 1624291 (MGI:MGI:4362003, PMID:16611247) RGD MGI:MGI:4362003 , PMID:16611247 Scrib-APC-beta-catenin complex IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 spindle pole IEA UniProtKB-SubCell:SL-0448 1600115 GO_REF:0000044 UniProt GO_REF:0000044 synapse IDA 1299225 RGD synapse ISO RGD:1550466 1624291 (MGI:MGI:5608921, PMID:25232112) RGD MGI:MGI:5608921 , PMID:25232112 transcription regulator complex ISO RGD:733705 1624291 (PMID:11751639) RGD PMID:11751639 transcription regulator complex ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 transcription regulator complex ISO RGD:1550466 1624291 (MGI:MGI:2446944 more ... RGD MGI:MGI:2446944 more ... Wnt signalosome ISO RGD:1550466 1624291 (MGI:MGI:5440351, PMID:22899650) RGD MGI:MGI:5440351 , PMID:22899650 Wnt signalosome IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 Z disc ISO RGD:1550466 1624291 (MGI:MGI:81460, PMID:8821035) RGD MGI:MGI:81460 , PMID:8821035 Z disc IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 Molecular Function alpha-catenin binding ISO RGD:1550466 1624291 UniProtKB:Q54MH2 (MGI:MGI:2447521 more ... RGD MGI:MGI:2447521 more ... alpha-catenin binding IBA MGI:MGI:88276 more ... 13792537 PMID:21873635 GO_Central alpha-catenin binding IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 alpha-catenin binding IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 alpha-catenin binding ISO RGD:733705 1624291 UniProtKB:P35221 , UniProtKB:Q9UI47 (PMID:23136403), (PMID:7650039), (PMID:7890674) RGD PMID:23136403 more ... beta-catenin binding ISO RGD:733705 1624291 UniProtKB:O94993 , UniProtKB:P15884 (PMID:29739711) RGD PMID:29739711 beta-catenin binding IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 cadherin binding IDA 1299225 ; 70260 RGD cadherin binding IBA MGI:MGI:88276 more ... 13792537 PMID:21873635 GO_Central cadherin binding IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 cadherin binding ISO RGD:733705 1624291 UniProtKB:P12830 more ... RGD PMID:12734196 more ... cadherin binding IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 cadherin binding ISO RGD:1550466 1624291 PR:P09803 more ... RGD MGI:MGI:3037401 more ... cadherin binding IPI RGD:69280 1626295 RGD chromatin binding ISO RGD:1550466 1624291 MGI:MGI:1202879 (MGI:MGI:3038034 more ... RGD MGI:MGI:3038034 more ... chromatin binding IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 disordered domain specific binding ISO RGD:1550466 1624291 UniProtKB:P09803 more ... RGD MGI:MGI:5882917 , PMID:11121423 disordered domain specific binding IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 DNA-binding transcription factor activity IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 enzyme binding ISO RGD:733705 1624291 UniProtKB:Q13526 more ... RGD PMID:11533658 more ... enzyme binding ISO RGD:1550466 1624291 UniProtKB:Q9QUR7 (MGI:MGI:5432836 , PMID:22645310) RGD MGI:MGI:5432836 , PMID:22645310 estrogen receptor binding ISO RGD:733705 1624291 UniProtKB:P03372 (PMID:15304487) RGD PMID:15304487 estrogen receptor binding IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 I-SMAD binding ISO RGD:733705 1624291 UniProtKB:O15105 (PMID:18593713) RGD PMID:18593713 I-SMAD binding IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 ion channel binding ISO RGD:733705 1624291 UniProtKB:Q9UBN4 (PMID:19996314) RGD PMID:19996314 ion channel binding IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 ionotropic glutamate receptor binding IPI RGD:2738 4107027 RGD kinase binding ISO RGD:733705 1624291 UniProtKB:P49841 (PMID:8638126) RGD PMID:8638126 nitric-oxide synthase binding IPI RGD:3185 7777144 RGD nitric-oxide synthase binding IPI RGD:3186 7777144 RGD nuclear hormone receptor binding ISO RGD:733705 1624291 UniProtKB:P10275 (PMID:12799378) RGD PMID:12799378 nuclear hormone receptor binding IBA MGI:MGI:88276 more ... 13792537 PMID:21873635 GO_Central nuclear hormone receptor binding ISO RGD:1550466 1624291 UniProtKB:P51448 (MGI:MGI:2683830 , PMID:14687547) RGD MGI:MGI:2683830 , PMID:14687547 protein binding IPI RGD:620241 1599635 RGD protein binding ISO RGD:733705 1624291 UniProtKB:A1Z199 more ... RGD PMID:10706604 more ... protein binding ISO RGD:1550466 1624291 PR:O35625 more ... RGD MGI:MGI:1196720 more ... protein binding IPI UniProtKB:Q9WU10 8554288 PMID:16682528 UniProt protein binding IPI UniProtKB:P61810 8554317 PMID:10753743 UniProt protein binding IPI UniProtKB:P49841 632259 PMID:9482734 BHF-UCL protein binding IPI UniProtKB:O70239 4108508 PMID:10330181 BHF-UCL protein binding IPI RGD:1583309 2317776 RGD protein binding ISO RGD:12299678 1624291 UniProtKB:F1PBJ0 more ... RGD PMID:10873669 , PMID:8636221 protein binding IPI RGD:3169 1599271 RGD protein C-terminus binding ISO RGD:733705 1624291 UniProtKB:P25054 , UniProtKB:Q09472 (PMID:10773885), (PMID:15843474) RGD PMID:10773885 , PMID:15843474 protein C-terminus binding IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein kinase binding ISO RGD:1550466 1624291 UniProtKB:Q5S006 (MGI:MGI:5440351 , PMID:22899650) RGD MGI:MGI:5440351 , PMID:22899650 protein kinase binding IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein phosphatase binding ISO RGD:733705 1624291 UniProtKB:Q15262 , UniProtKB:Q92729 (PMID:16574648), (PMID:8663237) RGD PMID:16574648 , PMID:8663237 protein phosphatase binding IBA MGI:MGI:88276 more ... 13792537 PMID:21873635 GO_Central protein phosphatase binding IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein phosphatase binding IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein phosphatase binding ISO RGD:1550466 1624291 UniProtKB:O14522 (MGI:MGI:3689290 , PMID:16973135) RGD MGI:MGI:3689290 , PMID:16973135 protein-containing complex binding IPI RGD:620829 , RGD:69280 2313226 RGD protein-containing complex binding IPI RGD:69280 , RGD:1359485 2291902 heterooligomerization RGD repressing transcription factor binding ISO RGD:1550466 1624291 UniProtKB:P10071 (MGI:MGI:3709704 , PMID:17331723) RGD MGI:MGI:3709704 , PMID:17331723 repressing transcription factor binding IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 RNA polymerase II activating transcription factor binding ISO RGD:733705 1624291 UniProtKB:Q9NQB0 (PMID:19443654) RGD PMID:19443654 RNA polymerase II activating transcription factor binding IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 RNA polymerase II transcription factor binding ISO RGD:1550466 1624291 (MGI:MGI:3690195 more ... RGD MGI:MGI:3690195 more ... RNA polymerase II transcription factor binding IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 RNA polymerase II transcription factor binding IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 RNA polymerase II transcription factor binding ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 RNA polymerase II transcription factor binding ISO RGD:733705 1624291 UniProtKB:Q9UJU2 (PMID:12651860), (PMID:18193033), (PMID:18579517), (PMID:18936100) RGD PMID:12651860 more ... SMAD binding ISO RGD:733705 1624291 UniProtKB:O15105 (PMID:18593713) RGD PMID:18593713 transcription coactivator activity IEA UniProtKB:Q02248 , ensembl:ENSMUSP000000071301600115 GO_REF:0000107 Ensembl GO_REF:0000107 transcription coactivator activity IBA FB:FBgn0000117 more ... 13792537 PMID:21873635 GO_Central transcription coactivator activity IEA UniProtKB:P35222 , ensembl:ENSP000004953601600115 GO_REF:0000107 Ensembl GO_REF:0000107 transcription coactivator activity ISO RGD:1550466 1624291 (MGI:MGI:2386811 more ... RGD MGI:MGI:2386811 more ... transcription coactivator activity ISO RGD:733705 1624291 (PMID:11751639), (PMID:12651860), (PMID:12949260), (PMID:18193033), (PMID:9065402) RGD PMID:11751639 more ... transcription coactivator activity ISS UniProtKB:P35222 1600115 GO_REF:0000024 UniProt GO_REF:0000024 transcription factor binding ISO RGD:1550466 1624291 MGI:MGI:109330 more ... RGD MGI:MGI:3690195 more ... transcription factor binding ISO RGD:733705 1624291 UniProtKB:O43524 , UniProtKB:Q9UJU2 (PMID:15905404), (PMID:20123964) RGD PMID:15905404 , PMID:20123964
Gene-Chemical Interaction Annotations